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CHAPTER I 
 
GENERAL INTRODUCTION 
 
The esophagus and trachea are, respectively, digestive and respiratory organs that 
originate from a common progenitor, the anterior foregut endoderm, during 
embryogenesis. Perturbed foregut patterning in development can result in a spectrum of 
congenital malformations, such as esophageal atresia (EA), tracheoesophageal fistula 
(TEF), and tracheal agenesis (TA). Despite a common occurrence of foregut defects in 
humans, in particular EA with TEF, the molecular and cellular etiologies remain poorly 
understood, in part, due to lack of genetic mouse models that recapitulate the different 
types of abnormalities. Bmp signaling has been recognized as a critical player in many 
aspects during development, including lung morphogenesis; however, its role during 
normal and abnormal patterning of the esophagus and trachea has not been studied. The 
focus of my thesis work is to elucidate the role of Bmp signaling in anterior foregut 
patterning, specifically, the development of the esophagus and trachea.  
 
 
1 
Part I: Anterior Foregut Development 
 
Overview of foregut morphogenesis 
The esophagus and trachea are derived from a common anterior foregut 
endodermal tube which is surrounded by splanchnic mesoderm. Clonal lineage analyses 
have indicated that the anterior foregut endoderm emerges from the anterior definitive 
endoderm (ADE), which is contributed by cells at the most anterior end of the early and 
mid primitive streak (PS) during gastrulation (Figure 1.1) (Kinder, Tsang et al. 2001; 
Lawson and Schoenwolf 2003). These anterior primitive streak (APS) cells possess 
organizer properties (Levak-Svajger and Svajger 1974; Beddington 1994; Kinder, Tsang 
et al. 2001) and also contribute to the prechordal plate (PCP) mesoderm, the most rostral 
population of midline axial mesoderm (Sulik, Dehart et al. 1994). During gastrulation, the 
ADE moves rostrally and displaces the visceral endoderm (VE) into the extraembryonic 
yolk sac (Figure 1.1) (Thomas and Beddington 1996). The APS cells at late streak stage 
(E7.5), identifiable as the mouse node, give rise to precursor cells of the floor plate and 
notochord (Beddington 1994; Sulik, Dehart et al. 1994), with minimal contribution to the 
foregut endoderm (Kinder, Tsang et al. 2001). At this time, the future notochord forms as 
a plate and is embedded in the dorsal gut endoderm, hence transiently participating in the 
formation of the roof of the primitive gut tube in rodent and human (Jurand 1974; Lamers, 
Spliet et al. 1987; Sulik, Dehart et al. 1994; Cleaver and Krieg 2001; Muller and 
O'Rahilly 2003). At the early headfold stage (E8.0), the lateral edges of the flat endoderm 
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 begin to converge medio-ventrally through a complex process of differential growth and 
embryonic folding that starts at the cephalic and lateral regions and progresses caudally. 
The movements by which the future ventrally-positioned foregut is brought to the midline 
also serve to bring the associated splanchnic mesoderm into the prospective medial 
position. During this period, cells of the notochordal plate coalesce and fold off into a 
rod-shaped structure (Jurand 1974; Lamers, Spliet et al. 1987; Sulik, Dehart et al. 1994; 
Cleaver and Krieg 2001; Muller and O'Rahilly 2003). The notochord moves dorsally, 
eventually separating from the endoderm and lying underneath the neural tube where it 
functions as a signaling center to pattern the adjacent embryonic structures and 
subsequently becomes the axis of the developing vertebral column (Stemple 2005).  The 
molecular mechanism regulating the detachment of notochordal plate from the dorsal gut 
endoderm in a timely manner is unknown (Jurand 1974; Sausedo and Schoenwolf 1994). 
By E8.5, the foregut tube is closed (Figure 1.1), and its most anterior portion gives rise to 
the thyroid, thymus, trachea, lung and esophagus (Wells and Melton 1999). 
Morphogenesis of the murine respiratory and digestive systems begins at around 
E9.5, when the respiratory primordium appears as a result of an endodermal outgrowth 
from the ventral wall of the foregut at the border with the pharyngeal endoderm 
(Kauffman 1992). Concomitant with the primary lung bud formation, the primitive 
trachea arises ventrally from a relatively more anterior portion of the foregut compared to 
the lung rudiments, and separates from the dorsal foregut, the primitive esophagus. By 
E11.5, division of the foregut is complete, yielding the trachea on the ventral side and the 
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Figure 1.2 Morphogenesis the esophagus and trachea.  
In mouse, at E9.5, shortly after formation of a closed foregut tube, separation of the 
esophagus and trachea begins, with two primitive lung buds appear as a result of an 
endodermal outgrowth from the ventral wall of the foregut at the border with the 
pharyngeal endoderm. Concomitant with the primary lung bud formation, the primitive 
trachea arises ventrally from a relatively more anterior portion of the foregut compared 
to the lung rudiments, and separates from the dorsal foregut, the primitive esophagus. By 
E11.5, division of the foregut is complete, yielding the trachea on the ventral side and the 
esophagus on the dorsal side (Kauffman 1992; Cardoso and Lu 2006). Es-esophagus; Tr-
trachea; Lu-lung. 
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esophagus on the dorsal side (Figure 1.2) (Kauffman 1992; Cardoso and Lu 2006). How 
the trachea and esophagus are specified and divided is not clear. Many models have been 
proposed to explain this morphogenetic process (Zaw-Tun 1982; Kluth, Steding et al. 
1987; Merei, Farmer et al. 1997; Possogel, Diez-Pardo et al. 1998). One theory suggests 
that the division results from fusion of the lateral ridges/folds that appear in the lateral 
wall of the foregut, which advances in a caudal to cranial direction (Skandalakis 1994). It 
is supported by histological examinations of the foregut (Qi and Beasley 2000; Orford, 
Manglick et al. 2001; Sasaki, Kusafuka et al. 2001; Williams, Qi et al. 2001); however, 
since the lateral ridges/folds do not appear to exist all the time, this once widely accepted 
concept has now been challenged (Zaw-Tun 1982; Kluth, Steding et al. 1987; Kluth and 
Fiegel 2003). Another more recent model proposes that the tracheo-esophageal separation 
is driven by the outgrowth and elongation of the respiratory primordium. The 
mesenchymal tissue that lies between the respiratory and digestive tubes constitutes the 
tracheo-esophageal septum which necessarily accompanies the separation of the 
esophagus and trachea (Zaw-Tun 1982; Sanudo and Domenech-Mateu 1990). This theory 
is supported by several studies which showed that the separation point of the respiratory 
and digestive systems remained at a constant somitic-vertebral level during downgrowth 
of the tracheal diverticulum (O'Rahilly and Muller 1984; Sutliff and Hutchins 1994; 
Williams, Quan et al. 2003). However, other investigators argue that the septum may 
actively move cranially along the foregut tube while the esophageal and tracheal tubes 
elongate posteriorly (Qi and Beasley 2000; Kluth and Fiegel 2003; Felix, Keijzer et al. 
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2004). Other theories also have been suggested, such as differential proliferation (Kluth 
and Fiegel 2003) and/or cell death that may play important roles in the separation process 
(Sutliff and Hutchins 1994; Zhou, Hutson et al. 1999; Qi and Beasley 2000; Williams, Qi 
et al. 2000).  
Foregut morphogenesis is a complex process of inductive interactions between the 
endoderm and its surrounding splanchnic mesoderm. Secreted signaling molecules 
produced by the mesenchyme such as Bmps, Wnts, and Fgfs may dynamically regulate 
the proliferation and/or differentiation of the endoderm in a paracrine fashion. Bmp 
signaling has been shown to play important roles during lung morphogenesis (Weaver, 
Yingling et al. 1999; Weaver, Dunn et al. 2000; Weaver, Batts et al. 2003); however, 
whether and how Bmp signaling is involved in patterning of the esophagus and trachea, 
physiologically or pathologically, still remains to be determined. 
 
Congenital foregut malformations 
Separation of the trachea and esophagus, a major developmental maneuver, 
presents enormous opportunities for malformations to occur. The occurrence of foregut 
anomalies is common in humans, approximately 1 in 3,000 live births (Skandalakis 1994). 
Based on their clinical manifestations, foregut defects have been divided into the 
following groups (Figure 1.3):  
(1) complete (agenesis) or partial (atresia) absence of the esophagus; 
(2) complete (agenesis) or partial (atresia) absence of the trachea; 
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…………………………………………………………………………………………….. 
Figure 1.3 Different forms of foregut malformations.  
Reprinted from Skandalakis 1994. 
 
9 
(3) stenosis of the esophagus; 
(4) stenosis of the trachea; 
(5) complete or partial failure of separation of the trachea and esophagus, which 
is often referred to as persistent foregut, or tracheoesophageal fistula (TEF, 
fistula refers to the abnormal connection). Normally, failure of separation does 
not affect differentiation. TEF is often accompanied with other defects in the 
esophagus and/or trachea, such as tracheal agenesis (TA) with 
tracheaoesophageal fistula (TA/TEF) and esophageal atresia (EA) with 
tracheaoesophageal fistula (EA/TEF).  
Approximately 1 in 4,000 babies are born with EA/TEF (Shapiro, Eddy et al. 
1958; Myers 1974; de Lorimier and Harrison 1985; Skandalakis 1994). About 50% of 
infants with EA/TEF have non-hereditary concurrence of three or more defects of various 
systems including the constellations known as VATER (vertebral or vascular, anal, TEF, 
EA, and radial limb or renal, a.k.a VACTERL [vertebral, anal, cardia, tracheal, 
esophageal, renal and limb]) and CHARGE (coloboma, heart defect, atresia choanae, 
retarded growth, genital, and ear anomalies) (Cano Garci-Nuno, Solis Sanchez et al. 1992; 
Kutiyanawala, Wyse et al. 1992; Torfs, Curry et al. 1995; Blake, Davenport et al. 1998; 
Tellier, Cormier-Daire et al. 1998; Shaw-Smith 2006). The cause of EA/TEF remains 
unknown but there are some associations with diabetic mothers (David and O'Callaghan 
1975; Aberg, Westbom et al. 2001), sex hormone exposure (Nora, Nora et al. 1978; 
Lammer and Cordero 1986), increase in maternal age (Torfs, Curry et al. 1995), 
10 
chromosomal abnormalities such as trisomies 13, 18 and 21 (Ein, Shandling et al. 1989; 
Kallen, Mastroiacovo et al. 1996; Beasley, Allen et al. 1997; Sparey, Jawaheer et al. 2000) 
and twinning (Orford, Glasson et al. 2000). EA/TEF has been further classified according 
to the type of esophageal defect and location of the fistula (Table 1.1). The most prevalent 
is Type C, occurring in about 86.5% of infants born with EA/TEF (Hicks and Mansfield 
1981; Engum, Grosfeld et al. 1995; Sparey, Jawaheer et al. 2000). In Type C EA/TEF, the 
esophagus, usually narrower than normal, fails to form a continuous tube connecting the 
oral cavity to the stomach; instead the upper esophagus simply ends in a blind pouch 
(EA), with the distal segment of the esophagus abnormally connected to the trachea via a 
fistula (TEF). While the survival rate after surgery to repair the abnormal fistula and 
reconnect the upper and lower esophagus has been tremendously improved for afflicted 
infants without other severe anomalies or associated problems (Sharma, Shekhawat et al. 
2000), nevertheless, the relatively high frequency of EA/TEF incidence does pose great 
clinical and familial burden.  
Tracheal atresia/agenesis are relatively rare congenital foregut anomalies (less 
than 1:50,000) that produce respiratory distress and are incompatible with life (Manschot, 
van den Anker et al. 1994). Though tracheal agenesis (TA) and tracheal atresia are 
different entities anatomically, which are characterized by partial and complete absence 
of trachea respectively, both fall into a spectrum of foregut defects, often referred to as 
tracheal atresia, whereby the trachea is underdeveloped/deformed to various degrees, 
resulting in disrupted communication between the larynx proximally and the lungs 
11 
 
Table 1.1 Different forms of esophageal atresia with tracheoesophageal fistula 
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 distally (Kerschner and Klotch 1997; Evans, Greenberg et al. 1999; Saleeby, Vustar et al. 
2003; Lander, Schauer et al. 2004). According to the anatomy, TA has been classified into 
three types (Figure 1.4) (Floyd, Campbell et al. 1962): type 1 refers to absence of the 
proximal (upper segment) trachea with a short segment of the distal trachea, which 
connects to the esophagus via a fistula; in type 2, the most common form, the entire 
trachea is absent with the main bronchi fused in the midline at the carina; in type 3, the 
entire trachea is also missing, but the main bronchi do not fuse in the middle. Instead, 
they arise separately from the esophagus. Like EA/TEF, babies born with TA are also 
often found to have defects in other organs. It has been suggested that TA could be part of 
the VA(C)TER(L) and TACRD (tracheal agenesis or laryngotracheal atresia, complex 
congenital cardiac abnormalities or ventricular septal defect, radial ray defects, and 
duodenal atresia) associations (Evans, Reggin et al. 1985; Diaz, Adams et al. 1989).  
While different in manifestation, foregut malformations were believed to have a 
common embryonic origin (Skandalakis 1994). It is thought that misregulation of 
signaling pathway(s) during a critical period of embryogenesis by environmental 
influences, such as exposure to certain teratogenic drugs or disease condition, could lead 
to those abnormalities, since familial occurrence of the congenital defect with associated 
anomalies is not common (Auchterlonie and White 1982; McMullen, Karnes et al. 1996; 
Nezarati and McLeod 1999). Although several theories have been proposed, such as 
intraembryonic pressure and abnormal development of the tracheoesophageal septum 
(Fluss and Poppen 1951; Moyson 1970; Merei and Hutson 2002), the etiology and  
13 
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molecular mechanism of foregut abnormalities remain obscure, in part due to short of 
embryos demonstrating different types of malformations (Evans, Greenberg et al. 1999; 
van Veenendaal, Liem et al. 2000; Merei and Hutson 2002; Saleeby, Vustar et al. 2003; 
Lander, Schauer et al. 2004). 
 
Animal models with foregut anomalies 
A few mutant mouse lines have been generated that exhibit, among other 
abnormalities, defects in tracheal and esophageal morphogenesis, such as Shh-/- lacking 
Sonic hedgehog (Shh) function (Litingtung, Lei et al. 1998; Pepicelli, Lewis et al. 1998); 
Gli2-/-;Gli3+/- , deficient in Shh signaling (Motoyama, Liu et al. 1998); Nkx2.1-/-, deficient 
in respiratory endoderm expression (Minoo, Su et al. 1999) and RARα-/-;β2-/- or RARα1-/-
;β-/-, deficient in retinoic acid receptors α and β2 function (Mendelsohn, Lohnes et al. 
1994). As shown in Table 1.2, in the Shh-/- and Gli2-/-; Gli3+/- foregut, the upper segment 
of the esophagus ends in a blind pouch and the lower segment appears to completely fail 
to separate from the trachea. The single foregut tubes observed in Nkx2.1-/- and RARα-/-; 
β2-/- or RARα1-/-;β-/- exhibit esophagotracheal characteristics. Haploinsufficiency of 
Foxf1, a member of forkhead family of transcription factors, displays a foregut phenotype 
highly reminiscent of Shh-/- foregut, and it has been suggested that Foxf1 is involved in 
Shh pathway, downstream of Shh (Mahlapuu, Enerback et al. 2001). Hoxc4 is a 
homeobox gene that encodes a highly conserved transcription factor. Hoxc4 null foregut  
15 
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exhibits a partially or completely blocked esophageal lumen and a disruption of 
esophageal musculature (Boulet and Capecchi 1996). Tbx4 belongs to the T-box family 
of transcription factors. An early study in the chick reported that it was expressed in the 
lung bud and trachea, where it was postulated to be involved in the separation of the 
trachea and esophagus (Gibson-Brown, S et al. 1998). Transient misexpression of Tbx4 in 
the prospective esophageal-respiratory region results in formation of tracheoesophageal 
fistula (Sakiyama, Yamagishi et al. 2003). The occurrence of grossly similar foregut 
defects by altering the functions of different genes suggests that multiple signaling 
pathways are likely to be involved in normal foregut tube morphogenesis. Notably, the 
foregut defects revealed in these mutant embryos are not highly reminiscent the Type C 
EA/TEF (Table 1.1), the most common form observed in humans. Additionally, no one so 
far has reported genetically altered mutant mouse models that exhibit tracheal 
atresia/agenesis. 
In addition to mutant mouse lines, an adriamycin rat/mouse model has also been 
used by investigators to study different types of foregut malformations, including Type C 
EA/TEF and TA. Adriamycin, an anthracycline antibiotic and chemotherapeutic drug 
(Young, Ozols et al. 1981; Tewey, Rowe et al. 1984; Muller, Jenner et al. 1997) with 
teratogenic potential, has been widely used to produce a spectrum of anomalies in 
developing rat and mouse fetuses, depending on the dose, duration and time of 
administration(Thompson, Molello et al. 1978). Intraperitoneal injection of pregnant 
females with adriamycin at E6.0-9.0 in rat or at E7.5-8.5 in mouse results in more than 
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50% of the embryos developing EA/TEF, some of which display Type C EA/TEF. 
Adriamycin-treated embryos can also display TA, although at a much lower frequency 
(about 3%) (Diez-Pardo, Baoquan et al. 1996; Possogel, Diez-Pardo et al. 1998; Qi and 
Beasley 1999; Ioannides, Chaudhry et al. 2002; Dawrant, Giles et al. 2007). A prominent 
abnormality in adriamycin-treated rat embryos is hypertrophy of the notochord with 
ventrally displaced branches making prolonged contacts with or in very close proximity 
to the dorsal foregut endoderm, raising the possibility that the abnormal notochord 
branches may contribute to the pathogenesis of EA/TEF (Possoegel, Diez-Pardo et al. 
1999; Qi and Beasley 1999; Orford, Manglick et al. 2001; Qi, Beasley et al. 2001; 
Williams, Qi et al. 2001; Mortell, O'Donnell et al. 2004). Efforts have been made to study 
possible alteration in Shh signaling in this context, based on the fact that Shh is expressed 
in the notochord and Shh signaling may function to pattern the adjacent tissues. In 
addition, adriamycin treatment can generate other defects similar to the VA(C)TER(L) 
association in humans, and defects in Shh signaling have been shown to exhibit a 
VA(C)TER(L) phenotype. However, molecular expression analysis of Shh target genes 
such as Patched1 (Ptch), which encodes a putative Shh transmembrane receptor, failed to 
provide evidence for ectopic Shh signaling in the adriamycin-treated foregut (Orford, 
Manglick et al. 2001).Taken together, although the adriamycin-treated embryo serves as a 
useful model to characterize the phenotypes of foregut abnormalities, the precise cellular 
and molecular mechanism of adriamycin action remains largely unknown. 
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Part II: Bmp Signaling and Embryonic Development 
 
The Bmp signaling pathways 
The bone morphogenetic proteins (Bmps) were originally discovered and hence 
named based on their bone and cartilage-inducing activities (Urist 1965; Urist, Mikulski 
et al. 1975; Urist, Nogami et al. 1976; Wozney, Rosen et al. 1988). Subsequent 
purification, cDNA cloning and functional studies revealed a large family of these 
secreted proteins, which play remarkable roles in many aspects of development, by 
regulating cell proliferation, survival, differentiation, migration and cell fate 
determination (Hogan 1996; Wozney 1998). To date, over 20 members of the Bmp family 
have been identified, in organisms ranging from Caenorhabditis elegans to humans 
(Balemans and Van Hul 2002; de Caestecker 2004). Based on their amino acid sequence 
homology and functional similarity, they can be grouped into subsets, such as 
Bmp2/4/Dpp and 60A subgroups (boxes in Figure 1.5).  
Bmps belong to the structurally related transforming growth factor β (Tgfβ) 
superfamily. Like all members of the Tgfβ superfamily, Bmps are initially synthesized as 
large precursors that contain a signal sequence and a pro-domain. These proteins are 
subsequently proteolytically cleaved to release the carboxy-terminal mature domains, 
which homo- or hetero-dimerize via a disulfide link to generate the active signaling 
molecules (Wozney 1992; Hogan 1996; Canalis, Economides et al. 2003). Bmps are 
distinguished from other Tgfβ superfamily members in that they have seven, rather than  
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Figure 1.5 Classes of Bmp members and relationships of Bmps with other Tgfβs. 
Within the Bmp family, members can be grouped into subsets based on the amino acid 
sequence homology, such as subgroups Bmp2/4/Dpp and 60A, as highlighted by boxes. 
Vertical arrow indicates increasing homology to Dpp. Adapted from Zhao et al., 2003. 
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nine, conserved cysteine residues in the mature domain (Griffith, Keck et al. 1996; 
Wozney 1998; Scheufler, Sebald et al. 1999). In addition, they signal through a 
structurally related set of receptors to activate a set of downstream effectors that are 
different from those activated by Tgfβ/Activin/Nodal (Massague and Chen 2000). 
Signaling by Bmps is mediated by a receptor complex consisting of type I and 
type II serine-threonine kinases, two distinct but related transmembrane proteins, both of 
which contain an extracellular ligand-binding domain composed of 10-12 cysteine 
residues capable of forming a three-finger toxin fold, a single transmembrane domain, 
and an intracellular serine-threonine kinase domain. The type I and type II receptors have 
different conserved sequences in their kinase domain. In addition, the type I receptors 
share a glycine/serine residue-rich domain (GS-box) in the juxtamembrane region, which 
is essential for type I receptor activation (ten Dijke, Korchynskyi et al. 2003). So far, 
three type I receptors are found to bind to Bmps, including Alk3 (Activin receptor-like 
kinase-3, a.k.a BmpR-IA), Alk6 (BmpR-IB) and Alk2 (ActR-IA) (Massague and Chen 
2000). Three type II receptors for Bmps have also been identified which are BmpR-II, 
ActR-IIA and ActR-IIB (Kawabata, Chytil et al. 1995; Rosenzweig, Imamura et al. 1995). 
While Alk3, Alk6 and BmpR-II are specific for Bmps, Alk2, ActR-IIA and ActR-IIB are 
also receptors for activins (Chen, Zhao et al. 2004).  
Upon ligand binding to the receptor complex, the constitutively active type II 
receptor transphosphorylates the associated type I receptor at serine residues in the GS 
box, resulting in conformational changes which allow the type I receptor to bind ATP and 
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subsequently phosphorylate its substrates, receptor-regulated Smads (R-Smads) (Huse, 
Muir et al. 2001). Bmps activate R-Smad1/5/8, not R-Smad 2/3, in that a cluster of 
residues within the L45 loop in the kinase domain of the Bmp-activated type I receptor 
(Alk2, 3, 6) tend to interact well with the L3 loop in the carboxy-terminus of R-
Smad1/5/8, whereas the Tgfβ/Activin/Nodal-activated type I receptors pair well with R-
Smad2/3 (Massague and Chen 2000). Following dissociation from the type I receptor, 
phosphorylated R-Smads heterodimerize with the common Smads (Co-Smads), Smad4, 
which itself cannot be phosphorylated by type I receptors, but its association with R-
Smads is necessary for intracellular transduction. The resulting heterdimeric Smad 
complex then translocates into the nucleus to activate or repress transcription depending 
on the recruited transcriptional co-modulators (Figure 1.6) (Massague and Wotton 2000; 
Shi and Massague 2003; Miyazono, Maeda et al. 2005). The specificity of Bmp signaling 
is controlled primarily by type I receptor. For instance, Bmp2 and Bmp4 primarily bind to 
Alk3 and Alk6, whereas Bmp7 binds to Alk2 with high affinity compared to Alk3 and 
Alk6 (Hsu, Rovinsky et al. 2005).  
In addition to the canonical Smad pathway, accumulating evidence suggests that 
Smad-independent pathways also exist to relay Bmp signals. In particular, an alternative 
Bmp-mitogen-activated protein kinase (MAPK) signaling pathway has been described 
(Figure 1.6), in which activation of Bmp-induced receptor complexes results in the 
activation of p38MAPK pathway, likely via TAK1 (Tgfβ Activated Kinase 1)-TAB1 (TAK 
binding protein). It appears that binding of Bmps to the preformed receptor complex 
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leads to activation of the Smad signaling pathway, whereas ligand binding to the homo-
oligomeric type I receptors and recruitment of the type II receptors results in activation of 
the alternative MAPK pathway. Studies have shown Ras and ERK can also be activated 
by Bmps, but not much is known about the mechanism (Kawabata, Chytil et al. 1995; 
Moustakas and Heldin 2005). 
 
Modulation of Bmp signaling 
Transduction of Bmp signaling is rather complex when one thinks about how 
Bmps mediate such diverse biological functions, with over 20 ligands, three type I and 
three type II receptors, and three Bmp-activated R-Smads and alternative intracellular 
effectors. Inside the nucleus, tissue/cell-specific expression of a combination of signaling 
components and recruitment of different co-factors (co-activators or co-repressors) can 
provide specificity toBmp signaling in that particular tissue or cell. In addition, Bmp 
signaling can be exquisitely regulated at the levels of extracellular space, cell surface or 
cytoplasm (Massague and Chen 2000; Nohe, Keating et al. 2004).  
Extracellularly, secreted polypeptide antagonists bind Bmp ligands and sequester 
them from their cognate receptors (Figure 1.6). Numerous Bmp antagonists have been 
identified, including Noggin, Chordin, and the DAN family (which includes Cerberus and 
Gremlin) (Smith and Harland 1992; Piccolo, Sasai et al. 1996; Hsu, Economides et al. 
1998; Pearce, Penny et al. 1999; Piccolo, Agius et al. 1999). Noggin, which was 
originally isolated and characterized as a component of the Spemann organizer in 
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Xenopus (Smith and Harland 1992), binds and inactivates Bmps by blocking the 
molecular interfaces of the binding epitopes for both type I and type II receptors (Groppe, 
Greenwald et al. 2002). Noggin binds Bmp-2, -4, -7, -5, -6, GDF-5, -6, and Vg1 with 
various degrees of affinity, but not other Tgfβ members (Zimmerman, De Jesus-Escobar 
et al. 1996; Canalis, Economides et al. 2003). Compared to Noggin, the cysteine-rich 
repeat protein Chordin plays a subtler role in modulating Bmp signaling. It acts as a sink 
for the ligands, thus preventing their binding to the receptors. Degradation of Chordin by 
specific proteases then releases the ligands and promotes receptor activation (Larrain, 
Bachiller et al. 2000; Larrain, Oelgeschlager et al. 2001). In additions to antagonists, 
heparin sulfate proteoglycans (HSPGs) in the extracellular matrix (ECM) may also 
sequester Bmps, thereby limiting their diffusion and/or availability to the receptors 
(Fisher, Li et al. 2006).  
On the cell surface, a transmembrane protein termed BAMBI (Bmp and Activin 
membrane-bound inhibitor) can block Bmp signaling by interfering with functional 
receptor complex formation. BAMBI is the Xenopus and Zebrafish orthologue of the 
mammalian Nma (Degen, Weterman et al. 1996; Onichtchouk, Chen et al. 1999) (Figure 
1.6). The extracellular domain of BAMBI has a sequence similar to type I receptors and 
its short intracellular domain lacks kinase activity. BAMBI binds to type I receptors, thus 
precluding their association with cognate type II receptors and phosphorylation of R-
Smads (de Caestecker 2004). During Xenopus embryogenesis, expression of BAMBI 
resembles that of Bmp4, and maintenance of BAMBI expression requires sustained Bmp 
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signaling, suggesting BAMBI functions as a negative feedback loop in Bmp signaling 
(Onichtchouk, Chen et al. 1999). 
Intracellularly, Bmp signaling can be modulated by actions of inhibitory Smads 
(I-Smads) 6 and 7, and Smad ubiquitination regulatory factors (Smurfs) 1 and 2. I-Smads 
compete with R-Smads for the association either with the activated type I receptor 
(Smad6 and 7) or with Co-Smads, i.e. Smad4 (Smad6) (Figure 1.6) (Miyazono 1999; 
Massague and Chen 2000; ten Dijke, Korchynskyi et al. 2003). As Smad7 constitutively 
interacts with HECT-domain ubiquitin ligases Smurfs1 and 2, Smad7 can also inhibit 
Smad signaling via receptor degradation. Upon recruitment of the Smad7/Smurf complex 
to the activated type I receptor, Smurf1 or 2 induces receptor degradation via proteasomal 
and lysosomal pathways (Kavsak, Rasmussen et al. 2000; Ebisawa, Fukuchi et al. 2001; 
ten Dijke, Korchynskyi et al. 2003). Smad6 has also been shown to inhibit Bmp-MAPK 
pathway by directly binding to and inhibiting TAK1 (Kimura, Matsuo et al. 2000; 
Massague and Chen 2000). In addition to the I-Smads, Smurfs have also been found to 
interact with R-Smads, thus targeting R-Smads for ubiquitin-mediated degradation by  
the proteasome (Figure 1.6) (Zhu, Kavsak et al. 1999; Zhang, Chang et al. 2001). 
 
Bmp signaling in foregut development 
Bmp signaling has always been a focus of biologists, since the time it was 
discovered (Urist 1965). It has proven to be an important pathway with roles in almost 
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every aspect of embryogenesis (Hogan 1996; Zhao 2003; Chen, Zhao et al. 2004; Pogue 
and Lyons 2006).  
As to the patterning of the anterior foregut, studies of Bmp signaling have focused 
on lung morphogenesis and, in particular, the role of Bmp4 during lung development. 
Two additional Bmps are expressed in the lung, i.e. Bmp5 and Bmp7; however, they are 
not essential for lung development based on their mutant phenotypes (King, Marker et al. 
1994; Dudley, Lyons et al. 1995).  In the mouse lung, two prominent domains of Bmp4 
expression have been reported. Bmp4 is expressed dynamically in epithelial cells at the 
distal tips of growing lung buds (Bellusci, Henderson et al. 1996), where it antagonizes 
fibroblast growth factor 10 (Fgf10) initiated outgrowth of lung bud which is critical for 
further branching of the distal endoderm (Weaver, Dunn et al. 2000). Overexpression of 
Xnoggin or a dominant negative Bmp receptor-dnAlk6 in the distal epithelium using the 
surfactant protein C (Sp-C) promoter/enhancer resulted in increased proximal cell types 
at the expense of distal cell types, indicating another critical role of Bmp4 in controlling 
proximal-distal patterning of the lung epithelium (Weaver, Yingling et al. 1999). Besides 
epithelial expression, Bmp4 is also expressed in the lung mesenchyme. Unlike the 
endodermally expressed Bmp4 at the distal tips, which is controlled by localized Fgf 
signals (including Fgf10), evidence indicates that this mesenchymal Bmp4 expression is 
induced by Shh expressed in the endoderm, suggesting that Bmp4 can be regulated by 
different signals in adjacent cell populations (Weaver, Batts et al. 2003).  
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In addition to its expression in the developing lung, Bmp4 has also been reported 
to be highly expressed throughout the ventral mesenchyme encompassing the future 
lungs and trachea at about E9.75 (27 somites) (Weaver, Yingling et al. 1999), thus raising 
the possibility that Bmp signaling may play a pivotal role in the morphogenesis of the 
trachea. However, assessing this potential biological function awaits generation of a 
mouse line that specifically deletes Bmp4 function in the ventral foregut domain, since 
Bmp4 null mutants exhibit early lethality and rarely survive past the egg cylinder stage 
(E6.5).  
 
Novel roles of Bmp signaling in patterning the esophagus and trachea 
To elucidate new roles of Bmp signaling in anterior foregut patterning, we took 
advantage of two genetic mouse models, i.e. Noggin (Nog) null embryos and Bmp4 
conditional mutants generated by Foxg1Cre.  
We have found that mouse embryos with complete loss of Noggin function 
display Type C EA/TEF, and notochordal abnormalities that are strikingly similar to those 
reported in adriamycin-treated rat embryos. In accord with esophageal atresia, Nog-/- 
embryos displayed reduction in the dorsal foregut endoderm which was associated with 
reduced adhesion and disrupted basement membrane. However, no significant apoptosis 
in the Nog-/- dorsal foregut was observed. Instead, non-notochordal, likely endodermal, 
cells were found in Nog-/- notochord suggesting that Noggin function is required in the 
notochordal plate for its proper delamination from the dorsal foregut. Notably, ablating 
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Bmp7 function in Nog-/- embryos rescued EA/TEF and notochord branching defects, 
suggesting a critical role of Noggin mediated Bmp7 antagonism in EA/TEF pathogenesis. 
Conditional ablation of Bmp4 in the ventral foregut region by a Foxg1Cre 
transgene resulted in loss of trachea. Further analysis indicated that the initial tracheal 
specification was unaffected; however subsequent outgrowth of the trachea was severely 
impaired. Consistent with the reduced growth capacity, the anterior foregut domain 
displayed significantly reduced epithelial and mesenchymal proliferation without 
apparent alterations in apoptotic cell death. While we did not observe alteration of Wnt/β-
catenin signaling in the Bmp4-deficient foregut, we detected consistent reduced 
expression of Shh, a signaling molecule known to promote cell proliferation, in the 
ventral foregut of Bmp4-deficient embryos. Therefore, these findings elucidate a critical 
role of Bmp signaling and cell proliferation in tracheal morphogenesis and implicate 
potential Bmp-Shh crosstalk in anterior foregut morphogenesis. 
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CHAPTER II 
 
ABERRANT BMP SIGNALING AND NOTOCHORD DELAMINATION IN THE 
PATHOGENESIS OF ESOPHAGEAL ATRESIA 
 
Introduction 
The esophagus and trachea are respectively dorsal and ventral derivatives of a 
common foregut tube. Abnormal development of these organs can lead to profound 
functional defects in humans. The most prevalent foregut malformation is known as Type 
C EA/TEF, which is characterized by an upper esophageal pouch and lower often 
severely stenosed esophagus that makes an abnormal connection with the trachea via a 
fistula (Hicks and Mansfield 1981; Engum, Grosfeld et al. 1995; del Rosario and 
Orenstein 1998; Clark 1999; Sparey, Jawaheer et al. 2000; Brunner and van Bokhoven 
2005). Despite the common occurrence of EA/TEF, the etiology and molecular 
pathogenesis of this developmental abnormality remain unknown. Feingold syndrome 
which is manifested by defects including intestinal atresia is one of a few such conditions 
that have been linked to a molecular defect (van Bokhoven, Celli et al. 2005). Several 
genetically-modified mouse mutants have been shown to display an array of foregut 
malformations indicating that foregut development is regulated by a complex genetic 
network (Mendelsohn, Lohnes et al. 1994; Litingtung, Lei et al. 1998; Motoyama, Liu et 
al. 1998; Pepicelli, Lewis et al. 1998; Minoo, Su et al. 1999).  
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Adriamycin is an antineoplastic antibiotic with teratogenic potential and has been 
widely used to induce EA/TEF and the VACTERL association in rat and mouse embryos 
(Thompson, Molello et al. 1978; Diez-Pardo, Baoquan et al. 1996; Beasley, Diez Pardo et 
al. 2000; Ioannides, Chaudhry et al. 2002). A prominent abnormality in adriamycin-
treated rat embryos is hypertrophy of the notochord with ventrally displaced branches 
making prolonged contacts with or in very close proximity to the dorsal foregut 
endoderm (Possoegel, Diez-Pardo et al. 1999; Qi and Beasley 1999; Orford, Manglick et 
al. 2001; Qi, Beasley et al. 2001; Williams, Qi et al. 2001; Mortell, O'Donnell et al. 
2004). However, the cellular and molecular mechanisms regulating notochord and 
endoderm interaction remain poorly understood. 
The notochord, a signaling tissue, functions as an organizer for adjacent 
embryonic structures and subsequently becomes the axis of the developing vertebral 
column (Stemple 2005). The notochord is initially formed as a plate with precursor cells 
embedded in the dorsal gut endoderm, hence transiently participating in the formation of 
the roof of the primitive gut tube in rodents and humans (Jurand 1974; Lamers, Spliet et 
al. 1987; Sulik, Dehart et al. 1994; Cleaver and Krieg 2001; Muller and O'Rahilly 2003). 
As development proceeds, cells of the notochordal plate coalesce and fold off into a rod-
shaped structure which eventually separates from the endoderm (Jurand 1974; Lamers, 
Spliet et al. 1987; Sulik, Dehart et al. 1994; Cleaver and Krieg 2001; Muller and 
O'Rahilly 2003). The molecular mechanism controling notochordal plate detachment 
from the dorsal gut endoderm in a timely manner is not known (Jurand 1974; Sausedo 
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and Schoenwolf 1994).  
We have found that mouse embryos with complete loss of Noggin (Nog) function 
display Type C EA/TEF with prominent narrowing of the esophagus. These embryos also 
display notochord abnormalities that are strikingly similar to those reported in 
adriamycin-treated rat embryos. The Noggin gene (Nog) contains a single exon and 
encodes a secreted polypeptide initially identified through its ability to antagonize Bmps 
to induce dorsal development in Xenopus embryos (Smith and Harland 1992). It was 
subsequently found that Noggin directly binds Bmps and inhibits their signaling during 
vertebrate development (Zimmerman, De Jesus-Escobar et al. 1996; Groppe, Greenwald 
et al. 2002; Canalis, Economides et al. 2003). In humans, NOGGIN (NOG) mutations 
have been linked to disorders affecting skeletal development (Krakow, Reinker et al. 
1998; Gong, Krakow et al. 1999); however, their association with visceral malformations 
has not been reported. In reviewing the literature, we have identified three EA/TEF 
patients having interstitial deletions in chromosome 22 that span the NOG locus (Park, 
Moeschler et al. 1992; Dallapiccola, Mingarelli et al. 1993; Marsh, Wellesley et al. 2000). 
In collaboration with Dr. Harold Lovvorn, here at Vanderbilt, we have obtained blood 
samples from patients with EA/TEF, and carried out a screen to look for point mutations 
within the NOG coding sequence. 
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Materials and Methods 
 
Generation and genotyping of Nog and Bmp7 mutant embryos and mice  
Nog hemizygotes were kindly provided by Dr. Richard Harland and Bmp7 mice 
(Luo, Hofmann et al. 1995) were obtained from the Jackson Laboratory. Both Nog+/- and 
Bmp7+/-;Nog+/- compound hemizygotes were maintained in either CD1 (ICR) or C57BL6 
background backcrossed for at least six generations, as a less penetrant phenotype was 
observed when mice were maintained in a mixed background. Since the foregut 
phenotypes were identical in either background, embryos maintained in the CD1/ICR 
background were used for the following studies.  
Genotyping of wildtype (WT) and Nog mutant alleles were performed as 
described (McMahon, Takada et al. 1998), using the following primers: 
Nog1, 5'-GCATGGAGCGCTGCCCCAGC-3'; 
Nog2, 5'-GAGCAGCGAGCGCAGCAGCG-3';  
Gal1, 5'-AAGG-GCGATCGGTGCGGGCC-3'.  
PCR conditions for both Nog WT and mutant alleles were: 94°C for 4 minutes; 40 cycles 
of (94°C for 30 seconds, 68.5°C for 40 seconds, 72°C for 45 seconds); 72°C for 10 
minutes. Amplifications of WT and mutant alleles generate a 211-bp product (primers 
Nog1 and Nog2) and a 160-bp product (primers Nog1 and Gal1), respectively. 
Genotyping for WT and targeted Bmp7 mutant (MT) alleles were determined by 
PCR using the following primers:  
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Bmp7 WT (forward), 5’-CTCAACGCCATCTCTGTCCTCTAC-3’;  
Bmp7 WT (reverse), 5’-CTGCTTGGTTTCCCTTCAACAC-3’;  
Bmp7 MT (forward), 5’-GGCAAAGGATGTGATACGTGGAAG-3’;   
Bmp7 MT (reverse), 5’-CCAGTTTCACTAATGACACAAACATG-3’.  
PCR conditions for Bmp7 WT and mutant alleles were: 94°C for 4minutes; 35 cycles of 
(94°C for 30 seconds, WT-58.8°C/MT 55°C for 40 seconds, 72°C for 45 seconds); 72°C 
for 10 minutes. Amplifications of WT and mutant alleles yield a 503-bp product and a 
850-bp product, respectively.  
 
Antibody production  
Anti-Foxa2 antibody was generated in rabbits against a purified bacterially-
expressed GST fusion protein containing 127 N-terminal amino acids of mouse Foxa2 
(DNA construct kindly provided by Dr. H. Sasaki). GST-Foxa2N127 fusion protein was 
produced and purified according to standard protocol. Briefly, BL21 (deficient in ompT 
and lon proteases) harboring the expression construct GST-Foxa2N127 was pre-cultured 
in 50 ml LBA (LB+100μg/ml ampicillin) medium  overnight at 37°C and at 230rpm, and 
then cultured in large scale (20ml of overnight culture in 500ml LBA) at 37°C for 3-4 
hours until the OD600 reached 0.5-0.6. Expression of the GST fusion protein was induced 
with 0.2mM IPTG, followed by culturing at 37°C for 3 hours. The bacterial pellet was 
obtained by centrifugation of cultured medium at 4000rpm for 15 minutes at 4°C. GST 
fusion protein was purified with B-PERTM GST Fusion Protein Purification Kit (Pierce), 
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according to the manufacturer’s protocol. The eluted protein was assayed by SDS-PAGE 
and concentrated by Centricon30 (Millipore), then shipped to Cocalico Biological Inc. for 
injection. After evaluating the affinity of sample serum by Western blotting, a terminal 
bleed was collected and affinity-purified using a column of Affigel-10 beads (Bio-Rad) 
conjugated with GST-Foxa2 fusion proteins according to manufacturer’s instruction. 
 
Immunohistochemistry  
For whole-mount immunohistochemistry, embryos were fixed in 4% 
paraformaldehyde (PFA) for 2-4 hours at 4°C and washed with PBS three times, followed 
by overnight incubation in 100% methanol:DMSO (4V:1V) solution at 4°C with shaking 
on a nutator. Samples were then stored in 100% methanol at -20°C until use. To quench 
endogenous peroxidase activity, embryos were bleached with 100% 
methanol:DMSO:30%H2O2 (4V:1V:1V) solution for 5 hours at room temperature (RT), 
and then rehydrated into PBS through a series of methanol dilutions in PBS (75%, 50%, 
25%). Samples were permeabilized in PBS containing 2% TritonX-100 for 1 hour at RT, 
then blocked in PBTM (PBT+5% non-fat dry milk, PBT: PBS containing 0.2%Triton and 
0.1%BSA) for 2 hours at RT, prior to overnight incubation with primary antibody diluted 
in PBTM at RT. To remove unbound primary antibody, embryos were thoroughly washed 
in PBT for 5-6 hours with several changes (1 hour per wash), and then re-blocked in 
PBTM prior to overnight incubation with secondary antibody diluted in PBTM at RT. 
Specimens were washed in PBT with several changes for a whole day before being 
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transferred to DAB solution (one 10mg DAB tablet from Sigma, dissolved in 33ml PBS 
plus 0.1% Tween20 and filtered through 0.45μm filter to remove particles) and incubated 
for 30 minutes. Then 0.1% H2O2 was added into the DAB solution to initiate the 
enzymatic color reaction. Samples were kept in the dark during color development and 
checked periodically until signals were detected (normally 2 hours). Following several 
PBS washes, embryos were dehydrated in 100% methanol, and cleared in a solution 
composed of benzylbenzoate and benzyl alcohol (2V:1V) and subsequently photographed. 
For section immunostaining, staged embryos were fixed in 4% PFA for 1 hour at 
4°C and dehydrated in a series of methanol washes (25%, 50%, 75% 
methanol/PBS+0.1%Tween, and 2X 100% methanol), except for those used for 
immunostainings of Brachyury and p-Smad1 which were fixed in EFA solution (100% 
ethanol:37% formaldehyde:100% acetic acid 6V:3V:1V) for 3 hours at 4°C, as described 
(Li, Zhang et al. 2006). For paraffin embedding, samples were treated with the following 
solutions, for 30 minutes at each step: 100% methanol (RT); 1:1 methanol/xylenes (RT); 
xylenes (RT); 1:1 xylenes/paraffin (60°C); three changes of paraffin (60°C). Sections of 6 
μm thickness were collected on Superfrost Plus slides (Fisher). The procedure for section 
immunostaining was described previously (Li, Zhang et al. 2004). Briefly, slides were 
dewaxed in xylene (3X, 5 minutes each) and rehydrated through a series of ethanol/PBS 
washes (2X 100% ethanol, 2X 95% ethanol, 1X 70% ethanol, 3X PBS, 3 minutes each). 
Endogenous peroxidase activity was blocked in methanol with 3% H2O2 for 10 min at RT. 
After washing in PBS 3 times, sections were antigen-retrieved in Tris-EDTA buffer 
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(10mM Tris Base, 1mM EDTA Solution, 0.05% Tween 20, pH 9.0) for 20 minutes, using 
a Black and Decker Handy Steamer. Slides were slowly cooled down in retrieval solution 
on the lab bench for 20 minutes, and rinsed in PBS prior to 1-hour blocking in PBS 
containing 10% goat or donkey serum depending on the host of the secondary antibody. 
For detection of p-Smad1, the Tyramide Signal Amplification kit (Perkin Elmer) was 
used as described (Li, Zhang et al. 2006). Primary antibodies were added onto the slides 
and incubated overnight at 4°C, at the following dilutions: mouse anti-Nkx2.1 (Lab 
Vision, 1:200); rat anti-E-cadherin (Zymed, 1:200); rabbit anti-ZO-1 (Zymed, 1:200); 
rabbit anti-laminin (Sigma-Aldrich, 1:50); goat anti-Brachyury (Santa Cruz, 1:500), 
rabbit anti-Foxa2 (1:10); rabbit anti-Sox9 (gift of Dr. Michael Wegner, 1:2,000); rabbit 
anti-Foxp4 (gift of Dr. Edward Morrisey, 1:400) and anti-phospho-Smad1/5/8 (gift of Dr. 
Peter ten Dijke, 1:1,500). After three 10 minutes washes in PBS, Alexa 488 (green)- or 
Alexa 568 (red)-conjugated secondary antibodies (Invitrogen) were applied at 1:500 
dilutions for 1.5 hours at RT in the dark. For counterstaining, Hoechst dye was used and 
shown in red or blue in appropriate figures. Some images were analyzed using FluoView 
1000 confocal microscope (Olympus).  
 
LacZ staining 
To detect Noggin-lacz expression, E7.5 to E9.5 embryos were dissected in cold 
PBS and fixed in 4% PFA on ice for 30 minutes. Embryos were then rinsed 3 times in 
cold PBS, and incubated in X-gal solution for 6 hours to overnight at 37°C. The reaction 
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was stopped by rinsing samples in PBS and post-fixing in 4% PFA for 20 minutes at RT. 
Embryos were then embedded in paraffin and sectioned as described above. 
 
Plastic thin section and cell death analysis 
E8.5 WT and Nog-/- embryos were fixed in 4% PFA at 4°C for 4 hours, 
dehydrated and embedded in JB-4 polymer according to manufacturer’s protocol 
(Polysciences Inc.). Embryos were then sectioned at 2 um, followed by staining with 1% 
toluidine blue solution.  
TUNEL assay was used for detection of apoptotic cells in embryo sections 
according to manufacturer’s instruction (ApopTag Apoptosis Detect Kit, Chemicon). 
 
In situ hybridization 
The synthesis of digoxigenin (DIG)-labeled probes was performed according to 
manufacturer’s protocols (Roche). Briefly, one in vitro transcription reaction (20μl) 
contains: 1μg of linearized DNA template (normally 2-4μl); 1X DIG RNA labeling mix 
(1mM ATP; CTP and GTP; 0.65mM UTP; 0.35mM DIG-11-UTP pH7.5); 1X 
transcription buffer; 40U RNasin (RNase inhibitor, Promega) and 50U of the appropriate 
RNA polymerase (T7,T3 or SP6). Transcription reaction was performed at 37°C for 2 
hours, and stopped by adding RNase-free DNaseI (20U) for 15 minutes at 37°C which 
destroys the template DNA. The labeled probes were precipitated with 3M sodium 
acetate (pH 5.2) and 100% ethanol, washed in 70% ethanol, resuspended in diethyl 
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pyrocarbonate (DEPC)-treated water and stored at -80°C. The following cDNAs were 
used as templates for synthesizing digoxygenin- labeled riboprobes: Pax9 (R. Balling); 
Bmp7 (E. Robertson); Foxa2 (H. Sasaki and B. L. Hogan); Hex (R.S.P. Beddington); 
Goosecoid (E.M. De Robertis); Mixl1(L. Robb); Bmp4 (S-J. Lee); Gli1 (C-c, Hui); Ptch1 
(M. Scott).  
Whole-mount in situ hybridization was performed according to a protocol from 
the De Robertis laboratory, with minor modifications. Embryos were fixed in 4% PFA 
(RNase-free) overnight at 4°C, rinsed in DEPC-PBS containing 0.1%Tween20 (PBTw), 
dehydrated through a series of methanol washes in DEPC-PBTw (25%, 50%, 75%, and 
2X 100% methanol), and stored at -20°C until use. Embryos were rehydrated into DEPC-
PBTw and treated with 15μg/ml proteinase K in DEPC-PBTw for various lengths of time 
(normally 3-12 minutes), depending on the location of tissue of interest, sample size and 
embryonic stage. After post-fixation in 4% PFA(RNase-free) containing 0.2% 
glutaraldehyde for 15 minutes at RT, embryos were rinsed in DEPC-PBTw, equilibrated 
with hybridization buffer (RNase-free, 50%formamide, 5X SSC, 1% Boehringer Block, 
1mg/ml torula RNA, 0.1mg/ml heparin, 0.1% Tween20, 0.1% CHAPS, 5mM EDTA) and 
prehybridized in hybridization buffer for at least 2 hours at 70°C. Hybridization solution 
containing about 0.2μg/ml probe was then added for overnight incubation at 70°C. On the 
following day, several washing steps were performed at 70°C: the hybridization solution 
was replaced by 800μl of hybridization buffer and washed for 5 minutes; 400μl 2XSSC 
(pH 4.5) was added twice into the vials and washed for 5 minutes each time; the washing 
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buffer was replaced and washed twice with 2XSSC containing 0.1%CHAPS (pH 7.0) for 
30 minutes each time. RNase treatment was then performed at RT, with 0.1%CHAPS 
containing 2XSSC plus 200μg/ml RNaseA, followed two 10 minute washes in MABT 
(0.1M maleic acid, 0.15M NaCl pH 7.5, and 0.1% Tween20) for 10 minutes each time. 
Embryos were washed in MABT twice at 70°C for 30 minutes each wash. RT wash in 
MABT was repeated once again for 10 minutes followed by two 10 minute washes in 
PBTw. Embryos were incubated in filtered blocking buffer (PBTw containing 10% goat 
serum plus 1% Boehringer blocking reagent) for at least 2 hours at 4°C.  Anti-DIG 
antibody conjugated to alkaline phosphatase (AP) (Roche) was added into the blocking 
buffer at 1:2,000 dilution for overnight incubation at 4°C. Samples were extensively 
washed 8-10 times in MABT for 1 hour each wash at RT, followed by overnight wash in 
MABT prior to the color reaction. For color development, embryos were first equilibrated 
by two 20 minute washes in NTM (0.1M Tris-pH9.5, 0.05M MgCl2, 0.1M NaCl) 
containing 0.1% Tween20 at RT. Chromogenic substrate BM purple (Roche) was then 
added into vials and incubation was carried at either 37°C or RT until specific signals 
were detected. The color reaction was stopped by rinsing in PBS, and post-fixed in 
4%PFA for 20 minutes.  
Section in situ hybridization was carried out as described (Hogan, Beddington et 
al. 1994), with some modifications. After dissection, embryos were directly embedded in 
Tissue-Tek® OCT compound in cold ethanol-dry ice bath and stored at -80°C.  
Cryosections at 15μm thickness containing desired embryonic regions were collected on 
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Superfrost Plus slides and dried in a 37°C incubator for 40 minutes, before being fixed in 
4% PFA for 20 minutes at RT. Slides were then washed twice in DEPC-PBS for 5 
minutes each time, followed by proteinase K treatment (2μg/ml in 50mM Tris pH7.5 and 
5mM EDTA) at RT for various lengths of time depending on the embryonic stage. After a 
brief rinse in DEPC-PBS, samples were post-fixed in 4% PFA for 15 minutes at RT. To 
enhance signaling, sections were treated for acetylation with 250ml 0.1M 
triethanolamine-HCl (pH 8.0) containing 0.625ml acetic anhydride. After two 5 minute 
washes in DEPC-PBS at RT, slides were incubated with hybridization buffer (same as in 
whole-mount hybridization) for at least 2 hours at 60°C until DIG-labeled probes were 
added onto slide at 1-2μg/ml and incubated overnight at 60°C. Unbound probes were 
removed by a series of washes in 1XSSC (60°C, 10 minutes), 1.5XSSC (60°C, 10 
minutes), 2XSSC (37°C, 20 minutes, twice), 2XSSC containing 0.2μg/ml RNaseA (37°C, 
30 minutes), 2XSSC (RT, 10 minutes), 0.2XSSC (60°C, 30 minutes, twice), PBTw (60°C, 
10 minutes, twice; RT, 10 minutes), and PBT (PBS containing 0.1% TritonX-100 and 
0.2% BSA) (RT, 15 minutes). Slides were incubated in blocking buffer (PBT containing 
20% goat serum) for at least 2 hours at RT, before anti-DIG antibody conjugated to AP 
was added into the blocking buffer at 1:,2000 dilution for overnight incubation at 4°C. 
After three 30 minute washes in PBT at RT, sections were equilibrated in NTM without 
or with 5mM levamisole for 5 minutes each time and incubated in BM Purple at 37°C 
until specific signals were detected. The color reaction was stopped by rinsing slides in 
PBS. 
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Genetic screening of point mutations within the NOG locus 
Blood samples were collected by our collaborator, Dr. Harold Lovvorn, from 
patients with EA/TEF (3ml for each patient), and stored at -80°C. Genomic DNA was 
extracted from blood samples using QIAamp spin column (Qiagen, CA). The NOG 
coding region was amplified by PCR with proofreading polymerase (9 units AmpliTaq 
Gold + 1 unit Pfu Turbo), using the following primers:  
NOG (Forward): 5’-GGACGCGGGACGAAGCAGCAG-3’; 
NOG (Reverse): 5’-GAGGATCAAGTGTCCGGGTGC-3’. 
The PCR condition was as follows: 94°C for 4minutes; 35 cycles of (94°C for 30 
seconds, 64°C for 60 seconds, 72°C for 60 seconds); 72°C for 10 minutes. The 765-bp 
PCR product was evaluated by electrophoresis. To prepare for TGCE (temperature 
gradient capillary electrophoresis) analysis, PCR fragments were denatured for 3 min at 
95°C and annealed in a thermal cycler via a stepwise reduction in temperature as follows: 
decrease from 95°C to 80°C at 3°C/min; decrease from 80°C to 55°C at 1°C/min; hold at 
55°C for 20 min; decrease from 55°C to 45°C at 1°C/min; and decrease from 45°C to 
25°C at 2°C/min(Li, Liu et al. 2002). Samples were sent for TGCE /Reveal analysis 
performed at the Vanderbilt Neuroscience Core. Samples that came out positive for SNP 
(single nucleotide polymorphism) were further evaluated by direct sequencing. 
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Results 
 
Nog-/- embryos displayed foregut reduction and Type C EA/TEF  
The respiratory bud is discernible as an outpocketing of the ventral foregut tube at 
E9.5 (Figure 2.2A) to give rise to the trachea and lung while the dorsal foregut develops 
into an esophagus which is clearly seen at E10.5 by immunolabeling Foxa2, an endoderm 
marker (Figure 2.1C). We found that Nog-/- embryos displayed Type C EA/TEF (Figure 
2.1D, B), consisting of an upper esophageal pouch (red arrowheads in B, D) while the 
lower stenosed esophagus as highlighted by an esophageal marker Pax9 (Neubuser, 
Koseki et al. 1995) (Figure 2.1E, F), makes an abnormal connection with the trachea 
(Figure 1.1B, D, black arrowheads); this phenotype is highly reminiscent of the most 
common form of EA/TEF in humans (Hicks and Mansfield 1981; Engum, Grosfeld et al. 
1995; Clark 1999). While most Nog-/- embryos displayed Type C EA/TEF (27/33 or 
82%), a few embryos showed a milder phenotype indicative of esophageal stenosis (6/33 
or 18%; Figure 2.1B, inset).  
We observed dorsoventral reduction in the Nog-/- foregut at E9.5 (Figure 2.2B, 
arrowheads, n=6) compared with WT (Figure 2.2A). We next investigated whether there 
was specific reduction of dorsal foregut endoderm since we observed narrowing of the 
esophagus relative to the trachea. Interestingly, by immunolabeling with Nkx2.1 to 
demarcate the respiratory (ventral) from the dorsal foregut at E9.5 (Minoo, Su et al. 
1999), we observed specific reduction of the dorsal foregut in Nog-/- compared with WT  
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Figure 2.1 Nog-/- foregut displays Type C EA/TEF. 
Whole-mount Foxa2 immunostaining of WT (A, C) and Nog-/- embryos (B, D) at E11.5 
(A, B) and E10.5 (C, D). In Nog-/- foregut, the upper esophagus ends in a blind pouch 
(red arrowheads in B, D); the lower esophagus, which expresses an esophageal marker 
Pax9 (F), connects to the trachea via a fistula (black arrowheads in B, D). While most 
Nog-/- embryos display Type C EA/TEF (27/33 or 82%), a few embryos show a milder 
phenotype indicative of esophageal stenosis (6/33 or 18%; B, inset).es, esophagus; tr, 
trachea. Magnification: A, B, 500X; C, D 900X; E, F, 200X. 
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(Figure 2.2C, D, dotted outline), consistent with esophageal defects in Nog-/- embryos. By 
contrast, the respiratory domain in Nog-/- embryos appeared comparable with WT 
embryos (Figure 2.2C, D), which is consistent with the observation that Nog-/- foregut 
developed ventral structures, the trachea and lung (Figure 2.1B).  
We also examined earlier embryos to determine if foregut endoderm defects 
observed in Nog-/- embryos could be due to abnormal endoderm tube formation. The 
foregut endoderm originates from the anterior definitive endoderm, contributed by cells 
at the most anterior end of the early and mid primitive streak during gastrulation (Kinder, 
Tsang et al. 2001). As morphogenesis progresses, the lateral edges of the flat endodermal 
sheet begin to converge medio-ventrally by a complex process of differential growth and 
embryonic folding. By E8.5, the foregut tube is closed followed by further growth and 
patterning (Wells and Melton 1999). We did not observe significant differences in the 
expression levels of several early mesendodermal markers (Figure 2.3); consistent with 
this observation, we did not detect differences in the size, cellular content (Figure 2.4 
A,B) or apoptotic cell death (Figure 2.4 C, D) of Nog-/- foregut tube at E8.5 (at somite 
stages 11-13s) compared with WT suggesting that foregut size reduction likely occurred 
after foregut tube formation. 
 
Nog-/- dorsal foregut endoderm failed to reveal significant apoptosis 
We reasoned that induction of apoptotic cell death within the dorsal foregut 
domain could be a mechanism by which dorsal foregut cells are lost resulting in  
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Figure 2.4 Plastic thin sections and TUNEL analysis of E8.5 embryos.  
(A, B) A toluidine blue-stained section shows no obvious differences in cellular 
morphology in the foregut endoderm of Nog-/- embryo compared to WT embryo. WT and 
Nog-/- foregut tubes are comparable in size and cellular content suggesting that gut size 
reduction likely occurs after foregut tube closure. (C, D) TUNEL assay shows no 
appreciable cell death in the Nog-/- dorsal endoderm as compared to WT endoderm. n, 
notochord; fg, foregut. Magnification, 200X. 
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esophageal atresia/stenosis. However, we did not observe significant apoptotic cells 
within the dorsal foregut domain of Nog-/- embryos between E9.0-9.75 (18-25s), a 
developmental window in which we observed dorsal foregut reduction (Figure 2.5).  
 
Nog-/- embryos displayed notochord detachment defects 
In addition to foregut defects, we observed morphologically abnormal notochord 
in Nog-/- embryos at E8.5 (Figure 2.2H) and E9.0 (Figure 2.2F), indicating delayed 
detachment from the dorsal foregut endoderm. Nog-/- notochord also appeared 
hypertrophic compared with WT notochord at E9.0 (Figure 2.2F). By contrast, WT 
notochord cells appeared more tightly packed in a rod-like structure and showed clear 
delamination from the dorsal foregut endoderm (Figure 2.2E, G). We observed cells 
positive for the notochord marker Brachyury (T+) still embedded within the dorsal 
foregut at E8.5 in Nog-/- embryos (Figure 2.2 J, L, arrows). Laminin immunostaining in 
these sections also revealed a clear basement membrane abutting the WT notochord and 
gut endoderm; by contrast, the boundary between notochord and endoderm was not 
clearly demarcated in Nog-/- embryos. Notochord defects persisted at later stages in Nog-/- 
embryos with lateral branches in close proximity or tethered to the dorsal foregut at E9.5 
(Figure 2.2B, arrows) in contrast with WT notochord (Figure 2.2A).  
As mentioned earlier, although no significant apoptosis was detected in the Nog-/- 
dorsal foregut, we did observe increased apoptotic cells in the notochord branches 
compared with WT foregut by TUNEL labeling (Figure 2.5). Even though notochord  
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branches in Nog-/- embryos were clearly apparent by E9.25 (20s, Figure 2.5F), we 
detected increased number of apoptotic cells in these branches at a slightly later stage 
when the lung buds have clearly emerged between E9.5-E9.75 (23-25s, Figure 2.5 G, H).  
 
Presence of non-notochordal cells in Nog-/- notochord 
The notochord is initially formed as a plate with cells embedded in the dorsal gut 
endoderm, and as development proceeds, cells of the notochordal plate coalesce, fold off 
and precisely detach from the dorsal gut endoderm (Jurand 1974; Sulik, Dehart et al. 
1994). It is possible that imprecise detachment of the notochord due to its prolonged 
contact with the dorsal endoderm may account for the loss of dorsal foregut endodermal 
cells in Nog-/- embryos. In support of this model, we detected cells in the Nog-/- notochord 
that were negative for notochord marker expression at E9.0 (17-18s). While notochord 
cells are normally positive for both T and Foxa2 (T+/Foxa2+), gut endoderm cells are T− 
but Foxa2+  and surrounding mesodermal cells are T−/Foxa2− (Figure 2.6A, C). We 
consistently found T−/Foxa2+ cells amongst T+/Foxa2+ cells in the Nog-/- notochord while 
WT notochord contained only T+/Foxa2+ cells (Figure 2.6B, D, arrowheads) (n=5 
embryos for each genotype). This finding is indicative of the presence of non-notochordal 
cells, likely Foxa2+ endodermal cells, within the Nog-/- notochord. We did not observe T-
/Foxa2+ cells in the surrounding mesenchyme suggesting that endodermal cells are 
unlikely becoming lost in the mesenchyme. Sox9, a SRY-related transcription factor, is 
expressed in the notochord and surrounding mesoderm but not in the dorsal foregut  
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Figure 2.6 Presence of non-notochordal cells in Nog-/- notochord. 
T (Brachyury) and Foxa2 double immunostaining of E9.0 embryos shows T-negative and 
Foxa2-positive cells in the Nog-/- notochord (D, E, arrowheads), but not in WT notochord. 
In agreement, Nog-/- notochord contains Sox9-negative cells (F, arrowheads), indicative 
of non-notochordal cells. Immunofluorescence color designations are: T (red), Foxa2 
(green), Merge (yellow), Sox9 (green) and nuclei are stained with Hoechst dye. n, 
notochord. Magnification: 400X. 
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endoderm (Stolt, Lommes et al. 2003).We therefore took advantage of this differential 
expression to examine whether Nog-/- notochord contained cells that do not express Sox9. 
As predicted, we found that Sox9− cells were consistently present in the Nog-/- notochord 
which likely indicate endodermal cell types (Figure 2.6E, F, arrowheads). Taken together, 
these results are suggestive of the presence of non-notochordal cells, likely Foxa2+ 
foregut endodermal cells, intermingled with notochord cells in Nog-/- embryos. 
 
Nog-/- dorsal foregut endoderm displayed concomitant cell loss, alteration in 
intercellular adhesion and matrix disruption 
To investigate whether the Nog-/- dorsal foregut endoderm cells displayed 
alterations in cell-cell adhesion, we performed immunohistochemistry with epithelial 
markers such as E-cadherin, a component of cell adherens junctions, to highlight the 
foregut tube at E9.0 (17-18s). We consistently observed loosening or loss of dorsal 
foregut cells in Nog-/- embryos concomitant with reduced E-cadherin level (Figure2.7 A, 
B). We observed similar disruption of dorsal foregut endoderm by immunolabeling with 
an antibody against zona occludens-1 (ZO-1), a tight junction protein (Figure 2.7 C, D). 
We also observed basement membrane disruption as highlighted by laminin 
immunostaining in the dorsal foregut of Nog-/- embryos (Figure 2.7 E, F). Collectively, 
these results are in agreement with our findings above that dorsal foregut endoderm cells 
are likely displaced into the notochord resulting in dorsal foregut reduction in Nog-/- 
embryos. 
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Figure 2.7 Nog-/- dorsal foregut displays cell loss, alteration in intercellular adhesion 
and matrix disruption. 
Immunohistochemistry of foregut sections from E9.0 WT and Nog-/- embryos with E-
cadherin (A, B, green) and ZO-1(C, D, green) to highlight disrupted epithelial cell 
adhesion in the Nog-/- dorsal foregut region. Staining with basement membrane marker 
laminin (E, F,green) reveals disruption of matrix and apparent loosening of dorsal foregut 
cells in Nog-/- embryos compared to WT embryos. n, notochord. Magnification 400X. 
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Noggin-mediated Bmp7 antagonism in the pathogenesis of EA/TEF 
In order to gain insight into the spatial and temporal requirement of Noggin-
mediated Bmp antagonism during notochord-foregut separation, we compared expression 
patterns of Noggin and Bmps during early foregut development. Among a few Bmps that 
are expressed in the gastrulating embryo, Bmp7 expression shows a close association 
with that of Noggin in the anterior primitive streak and in the node where prospective 
notochordal cells are clustered and both Noggin and Bmp7 continue to be expressed in the 
notochordal plate during its delamination from the roof of the dorsal foregut endoderm 
(Lyons, Hogan et al. 1995; Dudley and Robertson 1997; McMahon, Takada et al. 1998) 
(Figure 2.8A). By immunolabeling with an affinity-purified antibody against 
phosphorylated Smad1/5/8 (pSmad1), we detected increased Bmp signaling in the 
notochord of Nog-/- embryos at E8.5 (somite 11-12) with reduced level by E9.0 (somite 
17-18) (Figure 2.8B) consistent with loss of Noggin function and in agreement with a 
critical role of Bmp antagonism during notochord-foregut detachment. By contrast, we 
did not detect ectopic Bmp signaling in the Nog-/- dorsal foregut endoderm and its 
surrounding mesenchyme (Figure 2.8B).  
We reasoned that if Noggin-mediated Bmp7 antagonism is critical for proper 
notochord-foregut separation, then ablating Bmp7 would be expected to alleviate 
abnormal notochord detachment, thus rescuing the dorsal foregut defect and EA/TEF in 
Nog-/- mutants. We found that ablating Bmp7 in Nog-/- embryos significantly rescued 
notochordal defects at E9.5 and we did not observe notochord branches in 8 of 9  
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Nog-/-;Bmp7-/- embryos (Figure 2.9E-H); one embryo showed a small branch in its 
notochord (inset in Figure 2.9H). As predicted, at E9.5, Bmp7-/-;Nog-/- foregut tubes 
showed rescue of the narrowing defect (Figure 2.9G, H). By contrast, Nog-/- littermates 
showed remarkable notochord defects in 16 of 19 embryos consistent with findings in 
Figure 2.1F. At E11.5, Bmp7-/-;Nog-/- embryos (8/8) showed rescue of EA/TEF (Figure 
2.9I-L); the caudal neural tube which was also defective in Nog-/- displayed a relatively 
normal phenotype in Bmp7-/-;Nog-/- (Figure 2.9A-D, arrowheads). We also observed 
normal E-cadherin expression in the dorsal foregut and only T cells in the notochord of 
Bmp7-/-;Nog-/- double mutant embryos (Figure 2.9M). Although the notochord branches 
observed in Nog-/- embryos were significantly reduced in Bmp7-/-;Nog-/-,  notochords in 
the double mutants still appeared slightly hypertrophic compared to WT, suggesting that 
removing Bmp7 is not sufficient to completely counteract the effect of Noggin loss in the 
notochord.    
 
Screening for point mutations in NOG locus in patients with EA/TEF 
The human NOG gene is localized to chromosome 17q22. While browsing the 
literature, we found three EA/TEF patients with interstitial deletions of chromosome 17 
that spans the NOG locus (Table 2.1). The deletion del(17)(q22q23.3) reported by Marsh 
et al. (Marsh, Wellesley et al. 2000) represents the minimal breakpoints for the EA/TEF 
phenotype, which is not observed in q23.2q24.3 and q23.1q23.3 deletions that fall outside 
of the NOG locus (Table 2.1). Therefore, 17q22 represents a critical chromosomal 
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Figure 2.9 The EA/TEF phenotype, foregut reduction and notochord defects in   
Nog-/- embryos are rescued by ablation of Bmp7.  
(A-D), external views of WT (A), Bmp7-/-;Nog+/+ (B), Bmp7+/+;Nog-/- (C) and Bmp7-/-
;Nog-/- (D) embryos at E11.5. Bmp7+/+;Nog-/- embryos displays characteristic open brain 
and caudal neural tube (arrowhead, C) phenotypes. In Bmp7-/-;Nog-/- mutants, the open 
caudal neural tube is rescued (arrowhead, D). As revealed by whole-mount Foxa2 
immunostaining, ablating Bmp7 in Nog-/- embryos significantly rescues notochord defects 
at E9.5 (H: 8/9 showed no obvious notochord branches; 1/9 showed a small branch in the 
notochord, see inset-arrowhead) as compared to the Nog-/- littermates (G). As in WT 
embryos (E), no foregut defects are observed in Bmp7-/-;Nog+/+ mutants (F). The foregut 
narrowing defect in Nog-/- (G, arrowheads) is rescued in Bmp7-/-;Nog-/- (H, arrowheads). 
At E11.5, while the Bmp7+/+;Nog-/- littermates displays either EA/TEF (K: 20/22) or a 
milder phenotype of esophageal stenosis (2/22), Bmp7-/-;Nog-/- foregut shows rescue of 
EA/TEF (L: 8/8). (M) Expression of E-cadherin in Bmp7-/-;Nog-/- dorsal foregut 
endoderm appears to be comparable with WT endoderm. Additionally, all cells in the 
Bmp7-/-;Nog-/- notochord are stained with T, like in WT. es, esophagus; tr, trachea. 
Magnification: A-D, 125X; E-H, 630X; I-L, 500X; M, 400X. 
 
61 
62 
 location for the EA/TEF gene(s). Notably, the majority of EA/TEF patients also have 
symphalangism (fused digits), a prominent feature in SYM1 and SYNS1, autosomal 
dominant disorders that affect skeletal development and known to be linked with NOG 
mutations (Krakow, Reinker et al. 1998; Gong, Krakow et al. 1999). It is also worth 
noting that the breakpoints in 17q22 reported by Khalifa et al (Khalifa, MacLeod et al. 
1993) are not associated with EA/TEF, and could be explained by differences in 
expressivity possibly caused by different genetic background. Taken together, the 
specific chromosomal aberrations identified in humans as well as our findings from Nog-/- 
mouse embryos provide a tentative link between EA/TEF and NOG mutations in humans. 
In collaboration with Dr. Harold Lovvorn (Department of Pediatrics, Vanderbilt 
University), 50 blood samples from patients with EA/TEF were collected and screened 
for point mutations within the NOG coding region, using REVEAL/TGCE (Temperature 
Gradient Capillary Electrophoresis) analysis. One sample (#5) turned out positive for 
heteroduplex formation (Figure 2.10), which is suggestive of mismatched nucleotides 
between two DNA strands. DNA sequencing revealed this sample carried a single 
nucleotide polymorphism (SNP) at position 468, i.e. T instead of C, which still makes 
proline, rather than a point mutation. 
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Figure 2.10 TGCE/REVEAL analysis identifies Sample #5 positive for a SNP. 
Arrow in the upper panel indicates an additional peak which is absent in the control, 
suggesting a mismatched nucleotide between two DNA strands. 
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Discussion 
Human foregut malformations known as EA/TEF occur in 1 in 4,000 live births 
and are of unknown etiology. We found that mouse embryos nullizygous for Noggin, 
which encodes a Bmp antagonist, exhibit the Type C condition (Figure 2.1). This novel 
finding constitutes the first genetic evidence linking Bmp signaling to Type C EA/TEF, 
suggesting perhaps this common foregut malformation in humans is associated with 
alterations in Bmp signaling.  
Our results indicate that Type C EA/TEF found in Nog-/- embryos at E10.5 and 
E11.5 correlate with a specific dorsal endoderm reduction observed at E9.5 (Figure 2.1 
and 2.2), which likely occurred after formation of the foregut tube (Figure 2.3). In 
addition to Type C EA/TEF, we also observed abnormal notochord branches making 
contact with the dorsal foregut in Nog-/- embryos, similar to those reported in the 
adriamycin-induced rat embryos (Possoegel, Diez-Pardo et al. 1999; Qi and Beasley 1999; 
Orford, Manglick et al. 2001; Qi, Beasley et al. 2001; Williams, Qi et al. 2001; Mortell, 
O'Donnell et al. 2004). In support of the hypothesis that prolonged association of 
notochord with dorsal foregut may account for the dorsal foregut endoderm loss, we 
found non-notochordal (T-/Foxa2+ and sox9-), likely foregut endodermal cells were 
present in the Nog-/- notochord, mingled with notochord cells (Figure 2.6). In contrast to 
the ventral foregut domain which is cellularly dense, only a few cells make up the dorsal 
foregut domain (Figure 2.2 K, L); therefore, it is possible that loss of just a few dorsal 
endodermal cells during notochord detachment can result in significant reduction of the 
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dorsal foregut at later stages. The possibility remains that T- or Sox9- cells in Nog-/- 
notochord may represent a subpopulation of aberrant notochord cells that failed to 
express these markers; however, it is unlikely that these cells would display selective loss 
of T or Sox9 expression while maintaining Foxa2 expression. This notion argues in favor 
of the presence of endodermal cells that are Foxa2+but T- within the Nog-/- notochord. 
Ideally, the fate of dorsal foregut endoderm cells in Nog-/- mutants should be traced but, 
to our knowledge, no dorsal foregut endoderm-specific gene promoter has been identified. 
We also investigated several markers such as Sox2, Sox3, Foxg1, Foxp4 (data not shown), 
but these markers were expressed in the notochord as well as the gut endoderm, likely 
due to a common mesendodermal origin during gastrulation (Kinder, Tsang et al. 2001).  
 While Nog-/- embryos displayed Type C EA/TEF, embryos with loss of Chordin 
(Chrd-/-), another Bmp antagonist, displayed a relatively normal esophagus and trachea 
(Figure 2.11), indicating a distinct function of Nog for proper notochord delamination 
from the dorsal foregut endoderm. Nog and Chrd share overlapping expressions in the 
anterior primitive streak during gastrulation. Ablation of both Nog and Chrd results in 
defective formation of ADE, the precursor of the foregut endoderm (Bachiller, 
Klingensmith et al. 2000). Formation of the foregut endoderm appeared normal in Nog-/- 
(Figure 2.3 and 2.4), implicating functional compensation by Chrd in Nog-/- embryos 
during gastrulation. Taken together, our finding suggests that while largely redundant 
with Chrd (Bachiller, Klingensmith et al. 2000), Nog also exhibits distinct and 
indispensable functions during development. 
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Figure 2.11 Chrd-/- embryos displayed normal esophagus and trachea. 
             es, esophagus; tr, trachea. Magnification: 500X 
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We have shown that ablating Bmp7 alleviated the EA/TEF and foregut endoderm 
reduction observed in Nog-/- embryos (Figure 2.9). It remains possible, however, that 
other Bmps secreted from the ventral foregut mesoderm may also contribute to an 
increase in Bmp signaling in the notochord. During the course of this work, another 
group also reported a similar phenotype using Noggin mutant mice (Que et al., 2006). In 
their study, they rescued EA/TEF defect by partial removal of Bmp4, which is normally 
present in the ventral foregut mesoderm. 
Our genetic screen for point mutations within the human NOG locus did not 
identify any point mutation, except a single nucleotide polymorphism (SNP) in one 
patient. However, since we have not examined potential mutations in the promoter 
region, it remains possible that NOG gene could be misregulated (suppressed) in some of 
these patients due to abnormal promoter activity. Another plausible explanation is that 
most EA/TEF cases may be the result of misregulated Bmp signaling caused by 
environmental influences, such as exposure to certain teratogenic drugs or presence of a 
disease condition, other than genetic inheritance. This is supported by the fact that 
familial occurrence of the congenital defect with associated anomalies is not common 
(Auchterlonie and White 1982; McMullen, Karnes et al. 1996; Nezarati and McLeod 
1999).      
Based on our results, we propose a model for the role of Noggin-mediated Bmp 
antagonism in dorsal foregut development and the pathogenesis of EA/TEF. We found 
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Figure 2.12 Schematic diagram showing abnormal notochord detachment and 
dorsal foregut reduction in Nog-/- embryos.  FP, floorplate. 
The domain of tracheal primordium (green) is based on Nkx2.1 expression data. 
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 that elevated Bmp signaling in the notochord results in its prolonged attachment to the 
roof of the dorsal foregut endoderm (Figure 2.12). While the molecular activity 
downstream of unregulated Bmp signaling that results in delay and improper notochord 
delamination remains to be elucidated, it is likely associated with perturbation of cell-cell 
interaction between notochord and the foregut endoderm as disruption of basement 
membrane is evident in Nog-/- embryos (Figure 2.2 and 2.7). This effect is likely due to 
ectopic Bmp signaling in the notochord as the mesenchyme in close proximity to the 
dorsal foregut endoderm did not show ectopic Bmp signaling (Figure 2.8). However, we 
cannot exclude the possibility that the interstitial mesenchyme may indirectly contribute 
to the notochord detachment and/or the dorsal foregut defect.  
The spectrum of foregut malformations, in particular, Type C EA/TEF 
characteristically displays a fistula between the narrowed esophagus and trachea. It is 
plausible to suggest that reduction of the dorsal foregut, which occurred prominently in 
the upper region, would result in a severely thin esophagus which may be disrupted at its 
weakest point forming a fistula to the trachea in close proximity. This notion is consistent 
with the observation that fistula formation can occur at different locations along the 
trachea and that a small fraction of Nog-/- embryos exhibited esophageal stenosis without 
TEF as expected if esophageal disruption did not occur. In human patients, acquired TEF, 
as opposed to congenital TEF, can occur from a variety of causes that result in injury to 
the esophagus and/or trachea such as aspiration of gastric contents, presence of foreign 
body in the esophagus, and prolonged mechanical ventilation (Pelc, Prigogine et al. 2001; 
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 Reed and Mathisen 2003; Imamoglu, Cay et al. 2004). Acquired TEF can also occur as a 
complication secondary to esophageal or pulmonary malignancy. Thus, it appears that 
TEF can occur as a consequence of esophageal perturbations but the cellular mechanism 
of fistula formation remains to be determined.  
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CHAPTER III 
 
CONDITIONAL ABLATION OF BMP SIGNALING IN THE VENTRAL FOREGUT 
RESULTS IN TRACHEAL AGENESIS 
 
Introduction 
Development of the respiratory system, the trachea and lung, begins with ventral 
outpocketing of primitive lung buds from the anterior foregut endoderm, which is clearly 
discernible at E9.5 in mouse embryos (Kauffman 1992). Concomitant with primary lung 
bud formation, the tracheal primordium arises ventrally from a relatively more anterior 
portion of the foregut, and separates from the dorsal foregut, the primitive esophagus, in a 
complex process that is poorly understood. Division between the trachea and esophagus 
is complete by E11.5 (Kauffman 1992; Cardoso and Lu 2006). Defective development of 
these organs can lead to a spectrum of congenital malformations in humans ranging from 
esophageal atresia and tracheoesophageal fistula (EA/TEF) to tracheal agenesis (TA). The 
study described in this chapter focuses on TA which is characterized by complete absence 
of trachea (agenesis) or severe reduction of the trachea (atresia), such that communication 
between the larynx proximally and the lungs distally is lacking (Kerschner and Klotch 
1997; Evans, Greenberg et al. 1999; Sparey, Jawaheer et al. 2000; Saleeby, Vustar et al. 
2003; Lander, Schauer et al. 2004). It has been proposed that TA occurs due to failure of 
the tracheal tube to elongate (Effmann, Spackman et al. 1975; Lander, Schauer et al. 
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2004); however, the etiology and molecular pathogenesis of TA remain poorly understood. 
During anterior foregut development, inductive signals emanating from the 
underlying mesoderm, such as Fgfs and Bmps, are thought to pattern the ventral aspect of 
the foregut resulting in outgrowth of rudimentary buds that give rise to structures such as 
the lung, liver and ventral rudiment of the pancreas during an active period of 
organogenesis (Min, Danilenko et al. 1998; Sekine, Ohuchi et al. 1999; Rossi, Dunn et al. 
2001; Zaret 2002; Kumar, Jordan et al. 2003). For instance, during hepatogenesis, Bmp4 
produced in the septum transversum mesenchyme is required both for the induction of 
liver genes in the endoderm which would otherwise adopt a pancreatic fate, and the 
morphogenesis of the hepatic endoderm into a liver bud (Rossi, Dunn et al. 2001).  
Bmp4 belongs to the Tgfβ superfamily of cytokines, and has been implicated in 
various developmental processes (Hogan 1996; Zhao 2003; Pogue and Lyons 2006). Bmp 
signaling is mediated by receptor complexes consisting of type 1 (BMPR-1A/Alk3, 
BMPR-1B/Alk6 and ActR-I/Alk2) and type 2 (BmpRII, Act-RII and Act-RIIb) 
transmembrane receptor serine-threonine kinases. Type I receptor for Bmps 
phosphorylates R-Smad1/5/8, which then form heteromeric complexes with Smad4 to 
translocate to the nucleus where they bind cis elements associated with specific gene 
expressions in the regulation of diverse cellular processes such as proliferation, apoptosis, 
growth arrest and cell migration. (Massague 2000; Mishina 2003; Aubin, Davy et al. 
2004; Chen, Zhao et al. 2004; Kishigami and Mishina 2005).  
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Previous studies have shown that Bmp4 is expressed in the ventral foregut 
mesenchyme surrounding the lung primordium and the future trachea (Weaver, Yingling 
et al. 1999); however, the biological significance of this finding has not been assessed 
since Bmp4 null mutants exhibit early lethality, which hardly survive past the egg 
cylinder stage (E6.5) (Lawson, Dunn et al. 1999; Fujiwara, Dunn et al. 2001; Fujiwara, 
Dehart et al. 2002). We found that the distribution of phosphorylated-Smad1/5/8 (p-
Smad1), indicative of Bmp signaling, is restricted to the ventral foregut endoderm and 
mesenchyme, raising the possibility that Bmp signaling may be important in tracheal 
morphogenesis. In order to address the role of Bmp4 signaling in the ventral anterior 
foregut, we circumvented the early lethality of Bmp4 null embryos by conditionally 
ablating Bmp4 with Foxg1Cre (Bmp4cko), which, interestingly, resulted in the absence of 
trachea. Further analysis of Bmp4-deficient embryos indicated that specification of the 
tracheal primordium was unaffected; however, its outgrowth was severely compromised 
and was associated with significantly reduced tracheal epithelial and mesenchymal 
proliferation. The expression level of Sonic hedgehog (Shh), a proproliferative signaling 
molecule, was found to be significantly downregulated in Bmp4cko foregut. Consistently, 
we also found that expression of Cyclin D1, a key cell cycle regulator and known Shh 
downstream target, was reduced in the Bmp4cko foregut epithelium and mesenchyme. 
Taken together, these findings elucidate a critical role of Bmp signaling in tracheal 
morphogenesis and implicate potential Bmp-Shh crosstalk in anterior foregut growth. 
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Materials and Methods 
 
Mice and Embryos 
Bmp4loxp/loxp and Bmp4lacZ/+ mice were kindly provided by Drs. Brigid Hogan and 
Holger Kulessa. The Foxg1Cre transgene, ROSA26R and Top-Gal transgene were obtained 
from the Jackson Laboratory. All mouse strains were maintained in a C57BL/6 
background, except for ROSA26R, which is maintained in a mixed background. To 
characterize Foxg1 expression, Foxg1Cre was crossed with ROSA26R. Bmp4 conditional 
knockout (Bmp4cko) embryos were generated by crossing Bmp4flox/flox mice with 
Bmp4lacZ/+; Foxg1Cre mice and identified by Cre and Bmp4-lacZ PCRs (Figure 3.1), 
using the following primers: 
Cre (forward):5’-TCGATGCAACGAGTGATGAG-3’; 
Cre (reverse): 5’-TTCGGCTATACGTAACAGGG-3’; 
Bmp4-lacZ (forward): 5’-CAGGGCGATTCTTACTTTCG-3’; 
Bmp4-lacZ (reverse): 5’-AGCTTGGCGTAATCATGGTC-3’. 
Conditions for PCRs were: 94°C for 4minutes; 32 cycles of (94°C for 30 seconds, 55°C 
for 30 seconds, 72°C for 40 seconds); 72°C for 10 minutes. Amplifications of Cre and 
Bmp4-lacZ allele generate a 480-bp product and a 339-bp product, respectively. 
To study the effect of Bmp4 ablation on Wnt signaling, the Top-Gal transgene 
was introduced into Bmp4lacZ/+;Foxg1Cre before mating with Bmp4flox/flox homozygotes. 
Bmp4cko embryos containing Top-gal were determined by lacZ staining (see Results). 
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Immunohistochemistry and lacZ staining  
Immunohistochemistry and lacZ staining were performed as described in Chapter 
II (Li, Zhang et al. 2004), except for immunostaining of Nkx2.1 in embryos younger than 
E10 which was performed using cryosections. Briefly, embryos were fixed in 4% PFA at 
4°C for 40 minutes, washed in PBS 3 times, 10 minutes each, and embedded in Tissue-
Tek® OCT compound in cold ethanol-dry ice bath and stored at -80°C.  Cryosections at 
15μm thickness containing the desired embryonic regions were collected on Superfrost 
Plus slides and dried in a 37°C incubator for 10 minutes. After three 10 minute washes in 
PBS, slides were incubated in blocking solution (PBS+10% goat serum) containing 0.1% 
Triton-X100 for 1 hour at RT, prior to overnight incubation with primary antibody in 
blocking solution at 4°C. The remaining steps are the same as in immunohistochemistry 
for paraffin sections as described in Chapter II. Primary antibodies were used at the 
following dilutions:  rabbit anti-phospho-Smad1/5/8 (gift of Dr. Laufer 1:1500); rabbit 
anti-Foxa2 (1:50); mouse anti-Nkx2.1 (Lab Vision, 1:200); rabbit anti-Shh (Santa Cruz 
H-160, 1:200); rat anti-E-cadherin (Zymed, 1:200); mouse anti-CylinD1 (BD pharmingen, 
1:100); rabbit anti-CyclinD2 (Santa Cruz, M20, 1:150); and mouse anti-CyclinD3 (Lab 
Vision, 1:200).  
 
Analysis of cell proliferation and cell death 
Pregnant female mice at E9.5 were injected intraperitoneally with 5-
Bromodeoxyuridine (BrdU; 50mg per kg body weight) and sacrificed 30 minutes later. 
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Embryos were collected in cold PBS, fixed in 4% PFA for 1 hour at 4°C, dehydrated in a 
series of methanol washes (25%, 50%, 75% methanol/PBS+0.1%Tween, and 2X 100% 
methanol),  and embedded in paraffin (as described in Chapter II). Sections of 5μm 
thickness were collected on Superfrost Plus slides (Fisher). BrdU detection was 
performed as previously described (Litingtung, Lei et al. 1998). Briefly, slides were 
dewaxed in xylenes (3X, 5 minutes each) and rehydrated through a series of ethanol/PBS 
washes (2X 100% ethanol, 2X 95% ethanol, 1X 70% ethanol, 3X PBS, 3 minutes each). 
Endogenous peroxidase activity was blocked using 3% H2O2 in methanol for 10 minutes 
at RT. After washing in PBS for 3 times, sections were treated with 2N HCl at 37°C to 
expose the double-strand DNA. HCl treatment was stopped by several quick washes in 
water, followed by three 5 minute washes in PBS. After blocking in PBS containing 10% 
goat serum for 1 hour at RT, samples were incubated with mouse anti-BrdU antibody 
(Roche, 1:15 diluted in PBS+10% goat serum) overnight at 4°C. Slides were washed in 
PBTw (PBS+0.1% Tween20) 3 times for 10 minutes each, and incubated with goat anti-
mouse horseradish peroxidase (HRP) conjugated secondary antibody (Jackson 
ImmunoResearch, 1:300) for 1.5 hours at RT in the dark. Following extensive wash in 
PBS, slides were incubated in the dark with chromogenic substrate DAB (Invitrogen) 
until signals were detected (normally 3-10 minutes). Samples were counterstained with 
hematoxylin (Thermo Shandon) for 30 seconds, dehydrated in ascending ethanol series 
and mounted with Permount (Fisher).  
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TUNEL assay was used for detection of apoptotic cells in embryo sections 
according to manufacturer’s instruction (ApopTag Apoptosis Detect Kit, Chemicon). 
 
Statistic analysis 
Sections processed for BrdU detection were photographed at 200X magnification. 
Total number and percentage of BrdU-positive cells in Bmp4cko embryonic foreguts 
compared with WT littermates on five sequential sections of the upper foregut (anterior to 
lung primordium) per mutant or WT embryo were counted, with three pairs of embryos. 
All values were represented as means +/- standard error of the mean (SEM). Student’s t-
test was applied to determine statistical significance of differences between WT and 
Bmp4cko embryos. Statistical significance was defined as P<0.05. 
 
In situ hybridization   
Cryosection in situ hybridizations were performed as described in Chapter II. The 
following cDNAs were used as templates for synthesizing DIG-labeled riboprobes: Pax9 
(R. Balling), mCol2a (Y. Yamada), and Id1-3 (R. Benezra).  
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Results 
 
Conditional ablation of Bmp4 in the ventral foregut by Foxg1Cre transgene 
We observed that expression of Bmp4lacZ in the embryonic foregut was restricted 
to the ventral mesenchyme as early as E8.5 (Figure 3.2A). This restricted pattern 
remained until later stages when the trachea and esophagus are completely separated 
(Figure 3.2 E9.5-E11.5, B-D). Similarly, immunostaining of phosphorylated-Smad1/5/8 
(p-Smad1) was found restricted to the ventral mesoderm and endoderm in the anterior 
foregut at E9.0 (Figure 3.4 A, B). The role of this ventrally-restricted Bmp4 expression 
and signaling in anterior foregut growth and patterning has not been studied. We reasoned 
that morphogenesis of the trachea, a ventral endoderm derivative, would likely involve 
epithelial-mesenchymal interactions involving Bmp signaling. Therefore, to investigate 
the role of Bmp signaling in tracheal morphogenesis, we took advantage of a Foxg1Cre 
transgenic mouse line to specifically delete Bmp4 function in the ventral foregut domain. 
Foxg1 is expressed in the foregut endoderm as early as E8.5 (Figure 3.3 A-C), which is 
earlier than previously reported (Hebert and McConnell 2000). Foxg1 expression became 
more uniform and robust in both the foregut endoderm and mesoderm by E9.5, as 
highlighted by lacZ staining of embryos generated by crossing Foxg1Cre with ROSA26R 
(Figure 3.3 D-F). We generated conditional deletion of Bmp4 in the ventral foregut by 
crossing  Bmp4lacZ/+;Foxg1Cre mice with Bmp4flox/flox mice (Figure 3.1). Foxg1-mediated 
Cre activity is predicted to ablate Bmp4 function in the ventral foregut by E9.5 
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Figure 3.3 Foxg1 expression at E8.5 (A-C) and E9.5 (D-F), by lacZ staining of 
embryos from Foxg1CreXRosa26R. 
Lines in A and D denote the cross-section planes of B, C, E and F. Foxg1 is expressed in 
the foregut endoderm as early as E8.5 (A-C). Its expression becomes more uniform in 
both the endoderm and mesenchyme by E9.5 (D-F). fg-foregut. Magnification: A-400X; 
D-250X; B, C, E, F-200X. 
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Figure 3.4 Expression of p-Smad1/5/8, indicative of activated Bmp signaling, is 
reduced in E9.0 Bmp4cko foregut compared with WT foregut.  
(A, C) sections of WT embryos show ventrally restricted p-Smad1/5/8 expression (green) 
throughout the anterior foregut. (B, D) p-Smad1/5/8 staining is significantly reduced in 
the Bmp4cko embryos. The posterior half of the ventral foregut, close to the future lung 
bud level, displays some reduction in pSmad1/5/8 while loss of Bmp signaling appears to 
be even more dramatic in the anterior portion of the ventral foregut. fg-foregut. 
Manification: 400X. 
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 (Kulessa and Hogan 2002). 
Based on the early pattern of Bmp4 expression in the ventral mesoderm (Figure 
3.2), Foxg1Cre-mediated Bmp4 ablation in this tissue would likely affect Bmp4-mediated 
signaling in the ventral foregut mesoderm (autocrine) and in the endoderm (paracrine). 
We found substantial loss of Bmp signaling as demonstrated by significantly reduced p-
Smad1/5/8 immunostaining in the ventral foregut endoderm and mesoderm in Bmp4cko 
compared with WT embryos at E9.0, prior to the emergence of the respiratory 
primordium (Figure 3.4). We observed that the posterior half of the ventral foregut, at the 
future lung bud level, displayed some reduction in pSmad1/5/8 (Figure 3.4 C, D)while 
loss of Bmp signaling appeared to be more pronounced in the anterior portion of the 
ventral foregut (Figure 3.4 A, B). Based on pSmad1/5/8 staining, it appears that 
Foxg1Cre-mediated Bmp4 deletion occurred effectively in the anterior ventral foregut of 
all embryos examined (n=3).  
 
Expression of Id genes was downregulated in the Bmp4cko foregut  
To further confirm the conditional ablation of Bmp4, we also examined 
expression of inhibitor of differentiation (Id) genes, putative Bmp target genes in the 
ventral foreguts of Bmp4cko. Bmp signaling can transcriptionally regulate expression of Id 
genes which encode negative regulators of basic helix-loop-helix (bHLH) transcription 
factors (Hollnagel, Oehlmann et al. 1999; Miyazono and Miyazawa 2002; ten Dijke, 
Korchynskyi et al. 2003; Ying, Nichols et al. 2003). Id proteins have distinct functions in  
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Figure 3.5 Expression of Ids 1, 2 and 3 is downregulated in Bmp4cko foregut.  
        fg-foregut. Manification: 200X. 
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development and disease, and have been implicated in cell cycle regulation, G1 
progression and the control of growth induction (Barone, Pepperkok et al. 1994; Peverali, 
Ramqvist et al. 1994; Jen, Manova et al. 1997; Lyden, Young et al. 1999; Bain, Cravatt et 
al. 2001; Benezra, Rafii et al. 2001; Lasorella, Uo et al. 2001; Fong, Itahana et al. 2003; 
Ruzinova and Benezra 2003; Sikder, Devlin et al. 2003; Li, Luo et al. 2005). We found 
that all the Id genes (Id1, 2, 3) were expressed in both the ventral foregut mesoderm and 
endoderm while Id3 expression is relatively higher in the ventral foregut mesoderm 
compared to the endoderm (Figure 3.5 A, C, E). Therefore, we examined expression of 
Id1, Id2 and Id3 in the ventral foregut of Bmp4cko embryos by in situ hybridization on 
tissue sections at E9.25-9.5, compared with WT foreguts. In Bmp4cko embryos, expression 
of all three Ids was significantly downregulated in the ventral foregut (Figure 3.5 B, D, F), 
consistent with downregulation of Bmp signaling detected by pSmad1/5/8 (Figure 3.4). 
 
Bmp4-deficient foregut displayed trachea agenesis (TA) 
To determine the functional significance of this specific ablation, we examined 
the gross morphologies of Bmp4 conditional knockout (Bmp4cko) embryos by Foxa2 
immunohistochemistry to highlight the foregut endoderm (Litingtung, Lei et al. 1998). 
While there was no apparent morphological differences between WT and Bmp4cko foregut 
at E9.0 (Figure 3.6 A, B), a stage prior to the appearance of tracheal primordium, all 
Bmp4cko embryos displayed formation of a single tube, at E10.5 (n=3, Figure 3.6D) and 
E11.5 (n=3, Figure 3.6F), compared to WT littermates which exhibited two distinct gut  
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Figure 3.7 Nkx2.1 is expressed in the lung epithelium (arrows) of Bmp4cko embryos. 
es-esophagus. Magnification: 100X.  
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tube derivatives, the esophagus and trachea (Figure 3.6 C, E). In addition, we also 
observed hypoplastic lungs in all the Bmp4cko embryos examined (Figure 3.6 E, F insets), 
indicating an additional role of Bmp4 signaling during early lung bud growth. 
Molecular analysis of E12.5 embryos showed that the single tube in the Bmp4cko 
embryos did not stain with respiratory/tracheal specific marker Nkx2.1 (n=3, Figure 3.6 I, 
J), whereas Nkx2.1 expression could still be detected in the underdeveloped lung 
epithelium (Figure 3.7) (Minoo, Su et al. 1999). In contrast, Pax9, an esophageal specific 
marker, was able to label this endodermal tube (n=3, Figure 3.6 G, H). mCol2a expression, 
which normally surrounds the tracheal epithelium, was also lost in the ventral 
mesenchyme in Bmp4cko foregut compared to WT foregut (Figure 3.6 K, L). Taken 
together, these findings indicated that the single tube in Bmp4cko embryos has an 
esophageal characteristic and completely lacks tracheal identity, thus manifesting tracheal 
agenesis (TA). 
 
Specification of the tracheal primordium appeared normal in Bmp4cko embryos  
To determine whether loss of trachea is due to a tracheal specification problem, 
we examined the ventral foregut endoderm in Bmp4cko embryos by Nkx2.1 
immunostaining at E9.0-E9.5 (20-25 somites). At E9.0-9.25 (20-22 somites), prior to the 
appearance of the respiratory rudiment, Nkx2.1 was expressed in the Bmp4cko foregut and 
the extent of expression was quite comparable with WT foregut (Figure 3.8 A, B). As 
early as E9.25-9.5 (23-25 somites, Figure 3.8C, D), we observed a reduction in the  
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Figure 3.8 Specification of tracheal primordium appears normal in Bmp4cko embryos. 
Nkx2.1-positive cells (green) are present in the endoderm of Bmp4cko embryos at E9.0-9.5 
suggesting that the initial specification of the tracheal primordium is not affected. (A, B) 
Nkx2.1 immunostaining at E9.0-E9.5 (20-25 somites) reveals the extent of Nkx2.1 
expression is quite comparable in Bmp4cko embryos compared to WT embryos at E9.0-
9.25 (20-22 somites), prior to the appearance of the respiratory primordium. Note the 
fluorescence inside the lumen and close to the dorsal foregut is not nuclear and represents 
background staining. (C, D) Consistent with reduced growth capacity of the respiratory 
domain, the extent of Nkx2.1 expression, but not the expression level, is reduced in 
Bmp4cko embryos as early asE9.25- E9.5 compared with WT (23-25 somites). fg-foregut. 
Magnification: 400X. 
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expression domain of Nkx2.1, but not the expression level, in Bmp4cko embryos 
compared to WT embryos. The reduced extent of Nkx2.1 expression is consistent with 
the reduced foregut size in Bmp4cko embryos. The presence of Nkx2.1-positive cells in the 
endoderm of Bmp4cko embryos at E9.0 suggests that Bmp4-mediated signaling is required 
for the outgrowth, but not the initial specification, of the tracheal primordium.  
 
Bmp4cko foregut displays decreased cell proliferation but no significant alterations in 
cell survival and E-cadherin expression 
 To further investigate the decrease in growth potential of the Bmp4cko foregut, 
we determined the proliferative capacity of E9.5 WT and mutant foreguts by in vivo pulse 
labeling with 5’-BromodeoxyUridine (BrdU), a nucleotide analog that is incorporated 
into replicating DNA. We counted the total number and percentage of BrdU-positive cells 
in Bmp4cko embryonic foreguts compared with WT littermates on five sequential sections 
of the upper foregut per mutant or WT embryo in three pairs of embryos. WT and mutant 
embryos were paired based on somite number within the litters. We found a statistically 
significant difference in cell proliferation in the Bmp4cko foregut endoderm and mesoderm. 
BrdU pulse-labeling revealed a relatively lower percentage of proliferating epithelial cells 
in the Bmp4cko foregut (28.2-37.7%) compared with WT foregut (53.3-56.9 %). 
Mesenchymal cells in the Bmp4cko foregut also displayed a lower proliferative capacity 
(25.0-41.6%) compared with WT foregut (48.8-52.2%) (Figure 3.9).  
We also examined Bmp4cko foregut sections at E9.0-10.25 for alterations in the 
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Figure 3.10 Programmed cell death is not affected in the Bmp4cko foregut. 
fg-foregut. Magnification: 200X.  
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Figure 3.11 E-cadherin expression (green) is not altered in Bmp4cko foregut. 
        Magnification: 200X. 
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 level of cell death by TUNEL assay, and found no significant difference in apoptotic 
cells in the ventral foregut endoderm of Bmp4cko and WT embryos (Figure 3.10).  
Initiation of morphogenesis of organs such as the trachea/lungs, teeth and hair 
follicles involves outgrowth/downgrowth of an epithelial bud. Downregulation of E-
cadherin, an epithelial adherence junction protein, modulates Bmp and Wnt signaling to 
play a key role in epithelial bud outgrowth (Jamora, DasGupta et al. 2003). Although 
epithelial polarity and intercellular adhesion are essential to maintain epithelial integrity 
and function, it appears that disrupting epithelial adhesion is a critical step during 
epithelial bud morphogenesis. Therefore, we examined whether expression of E-cadherin 
may be altered in Bmp4cko. However, we did not observe alterations in the expression or 
localization of E-cadherin (Figure 3.11). 
Taken together, we propose that one critical role of Bmp4-mediated signaling in 
the foregut is to regulate cell proliferation during tracheal development. 
 
Wnt signaling was not affected in the Bmp4cko foregut epithelium  
To explore the molecular mechanism underlying cell proliferation modulation by 
Bmp4 signaling, we next investigated the potential alteration of Wnt signaling in Bmp4cko 
foregut, as several lines of evidence suggest that Bmp signaling may regulate cell 
proliferation/cell cycle progression via cross-talk with canonical Wnt signaling (Marcelle, 
Stark et al. 1997; Burstyn-Cohen, Stanleigh et al. 2004; Ovchinnikov, Selever et al. 2006). 
Transgenic Wnt/β-catenin signaling reporter Top-Gal expression can be detected at E9.5  
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Figure 3.12 Wnt/β-catenin signaling remains unaffected in Bmp4cko embryos. 
(A-C) Whole-mount view of lacZ stained E9.0-9.25 (20-22 somites) Bmp4-lacZ, Top-Gal 
and Bmp4-lacZ+Top-Gal embryos. Note specific expression of Top-Gal in the mid-brain 
ectoderm (black arrowheads in A, B) and Bmp4-lacZ in the limb mesoderm and mid-
hindgut (red arrows in A, B). Lines in C denote the cross-section planes of D-G.  (D-G) 
Endodermal Top-Gal expression levels remain unaltered in the Bmp4cko compared to 
control (Bmp4lacZ/flox) littermates.  The lacZ staining in the ventral mesenchyme is from 
Bmp4-lacZ allele (see Figure 3.2), which is present in both the control and Bmp4cko 
embryos. fg-foregut. Magnification: A to C-250X; D to G-200X. 
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in the developing anterior foregut endoderm at the level of the laryngotracheal groove 
and canonical Wnt activity persists in foregut endoderm derivatives at later stages 
(Okubo and Hogan 2004; Shu, Guttentag et al. 2005), suggesting that canonical Wnt 
signaling may play a key role in anterior foregut morphogenesis. We therefore introduced 
Top-Gal transgene into Bmp4lacZ/+; Foxg1Cre/+ mice and mated them with Bmp4flox/flox to 
obtain Bmp4cko embryos harboring Top-Gal. E9.0-9.25 (20-22 somites) embryos 
expressing both Bmp4-lacZ and Top-Gal upon lacZ staining were selected, based on 
specific Bmp4-lacZ expression in the limb mesoderm and mid-hind gut (red arrows in 
Figure 3.12 A, B) and distinct Top-Gal expression in the mid-brain ectoderm (black 
arrowheads in Figure 3.12 A, B). Bmp4cko were identified by Cre PCR. At E9.0-9.25, 
while Bmp4-lacZ was restricted in the ventral foregut mesenchyme (also refer to Figure 
3.2), Top-Gal expression was observed in the ventral endodermal layer, consistent with a 
previous report (Okubo and Hogan 2004) (Figure 3.12, D, F). To our surprise, we found 
that the Top-Gal expression in the Bmp4cko foregut was largely comparable to control 
(Bmp4lacZ/flox) littermates (Figure 3.12, E, G), indicating that Wnt/β-catenin signaling was 
not affected in Bmp4cko.     
 
Shh expression was reduced in the Bmp4cko embryos 
In addition to canonical Wnt signaling, there is also evidence suggesting that Bmp 
can cross-talk with Shh during palatogenesis and tooth germ development (Chen, Bei et 
al. 1996; Zhang, Zhang et al. 2000; Zhang, Song et al. 2002). Shh signaling has been  
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Figure 3.13 Expression levels of Shh are reduced in Bmp4cko foreut. 
Note decreased Shh expression levels occur only in the foregut region where Bmp4 is 
specifically ablated, but not in the notochord and floor plate. fg-foregut; n-notochord; fp-
floor plate. Magnification: 200X. 
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implicated in the regulation of cell proliferation during normal developmental processes 
in various organs, as well as under pathological conditions (Litingtung, Lei et al. 1998; 
Pepicelli, Lewis et al. 1998; Wetmore 2003; Ingham and Placzek 2006). Embryos with 
loss of Shh or defective in Shh signaling components displayed severe esophagotracheal 
defects suggesting a critical role of Shh signaling in foregut morphogenesis (Litingtung, 
Lei et al. 1998; Motoyama, Liu et al. 1998; Pepicelli, Lewis et al. 1998). Shh expression 
is normally restricted to the ventral foregut endoderm (Figure 3.13A, C); expressions of 
its target genes such as Gli1 and Ptch1 revealed that signaling occurred in both the 
ventral epithelium and mesenchyme (Litingtung, Lei et al. 1998; Pepicelli, Lewis et al. 
1998; and Yina Li and Chin Chiang, unpublished observation). We therefore examined 
the expression of Shh in Bmp4cko embryos. In contrast to Top-Gal expression, Shh level 
was consistently reduced in the Bmp4cko foregut at E9.25 and E9.5 (Figure 3.11B, D), and 
this reduction was specific in the foregut region where Bmp signaling was ablated, but 
not in the notochord and floor plate (Figure 3.13 A, B). This result suggests that the 
impaired proliferative capacity of Bmp4cko foregut is, at least in part, due to compromised 
Shh expression level.    
 
Expression of Cyclin D1 was downregulated in Bmp4cko 
Numerous publications have implicated the role of Shh signaling in the regulation 
of proproliferative genes such as Cyclins, which are evolutionarily conserved proteins 
essential for cell cycle control (Kenney and Rowitch 2000; Berman, Karhadkar et al. 
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2002; Ciemerych, Kenney et al. 2002; Mill, Mo et al. 2003; Yu, Mazerolle et al. 2006). 
Therefore, we next determined the expression of Cyclin D1-3, which are critical 
components for G1 to S progression. By performing immunohistochemistry on paraffin-
embedded tissue sections of Bmp4cko foreguts compared with WT at E9.5, we found the 
expression level and distribution of Cyclin D1 was reduced in both the epithelium and 
mesenchyme of Bmp4cko foregut (Figure 3.14B), compared with WT (Figure 3.14A), 
which is consistent with the impaired growth capacity observed in the epithelium and 
mesenchyme of the Bmp4cko foreguts (Figure 3.9). Compared to Cyclin D1, Cyclin D2 
and D3 were expressed at low levels in only a few foregut cells (Figure 3.14 C, E). 
Examination of these two D type Cyclins did not reveal appreciable differences between 
WT and Bmp4cko foreguts (Figure 3.14, C-F), suggesting that Shh signaling in developing 
foreguts does not affect cyclin D2 and D3, in contrast to its effect on Cyclin D1.  
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Figure 3.14 Expression of Cyclin D1-3 in the Bmp4cko foregut. 
Cyclin D1 expression in the foregut region is reduced in both the epithelium and 
mesenchyme in the E9.25-9.5 Bmp4cko embryos. However, there are no appreciable 
differences of Cyclin D2 and D3 expression between WT and Bmp4cko embryos. fg-
foregut. Magnification: A, B-400X; C to F-200X. 
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Discussion 
Tracheal atresia/agenesis is a rare but life-threatening foregut anomaly of 
unknown etiology (Diaz, Adams et al. 1989; Manschot, van den Anker et al. 1994; 
Kerschner and Klotch 1997). We found that mouse embryos with conditional ablation of 
Bmp4 in the ventral foregut domain by a Foxg1Cre transgene displayed tracheal agenesis 
(TA) (Figure 3.5). This novel finding provides the first genetic mouse model manifesting 
TA, and suggests perhaps TA in humans is associated with insufficient Bmp signaling 
during tracheal morphogenesis.  
Like lung development, tracheal morphogenesis is also governed by a complex 
process of inductive interactions between the endoderm and its surrounding mesoderm. In 
mouse embryos nullizygous of fibroblast growth factor 10 (Fgf10), which is normally 
expressed in the foregut mesoderm, the respiratory primordium failed to grow out while 
the presumptive trachea was still formed (Min, Danilenko et al. 1998; Sekine, Ohuchi et 
al. 1999), suggesting alternative signaling(s) from the mesoderm is required to regulate 
tracheal formation. Here we show that conditional ablation of Bmp4 in the ventral foregut 
domain led to a significant reduction in its growth capacity at E10.5 and E11.5 which 
resulted in loss of the trachea (Figure 3.6 C-F). Since we observed reduction in Bmp 
signaling in both the ventral foregut endoderm and mesenchyme (Figure 3.4), it is 
possible that mesenchymally-derived Bmp4 signals in a paracrine fashion to regulate the 
underlying foregut endodermal growth. In addition, it could also signal in an autocrine 
manner to affect the ability of mesenchymal cells to secrete growth factors or ECM 
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molecules which are critical for mesenchymal-epithelial interaction, epithelial growth and 
patterning. Bmp4 also appears to be expressed at low levels at a later stage in the ventral 
foregut endoderm (Figure3.2D, E10.5), therefore it is possible that Foxg1Cre-mediated 
ablation of epithelial-derived Bmp4 may also contribute to reduction of autocrine Bmp 
signaling in the epithelium at later stages.  
We detected significant reduction in Id1-3 expression in Bmp4cko foregut, 
consistent with these regulatory factors being downstream targets of Bmp signaling. The 
role of Id factors in modulating epithelial cell proliferation has been reported in several 
studies (Coppe, Smith et al. 2003; Kowanetz, Valcourt et al. 2004; Asirvatham, Schmidt 
et al. 2006; Hua, Zhang et al. 2006; Langenfeld, Kong et al. 2006). Members of the Id 
family are expressed in the foregut region and share significant redundant functions 
during development (Lyden, Young et al. 1999; Kee and Bronner-Fraser 2001; 
Fraidenraich, Stillwell et al. 2004). Id2 has also been implicated in distal lung epithelial 
growth (Komatsu, Shibuya et al. 2002). However, loss of Id function in the foregut as in 
Id2-/- (Mori, Nishikawa et al. 2000) or in Id1-/-;Id3-/- (data not shown) embryos did not 
result in tracheal atresia. Therefore, the role of Id proteins in tracheal morphogenesis 
remains to be elucidated. Possibly, due to redundant functions, tracheal development 
might be impaired when all three Id genes are deleted. 
The observation that Nkx2.1-expressing cells were still present in the Bmp4cko 
foregut and the expression level was comparable with WT E9.0 embryos suggests that 
Bmp4 is not required for the initial tracheal specification; rather, it plays an indispensable 
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role in the subsequent outgrowth of the trachea. This finding is different from the role of 
Bmp signaling in liver development, in which Bmp signaling appears to be essential for 
both initial hepatic fate specification and subsequent outgrowth of hepatic endoderm into 
liver buds (Zaret 2000; Rossi, Dunn et al. 2001; Zaret 2001). 
Consistent with the reduction in growth potential, we found that E9.5 Bmp4cko 
foregut showed reduced cell proliferation in the epithelium and mesenchyme by BrdU 
labeling, indicative of impaired cell cycle progression, in particular, G1-S transition. 
Several studies indicate that Bmp can modulate components of canonical Wnt signaling 
in embryonic development and cancer (Nishanian, Kim et al. 2004; Yang, Yamasaki et al. 
2006). Bmp has also been shown to regulate the cell cycle by controling Cyclin D1 
expression and G1/S transition via activation of canonical Wnt signaling during neural 
crest delamination, in particular, via transcriptional activation of Wnt1 in the dorsal 
neural tube (Marcelle, Stark et al. 1997; Burstyn-Cohen, Stanleigh et al. 2004). 
Surprisingly, we did not observe changes in reporter Top-Gal expression suggesting that 
Wnt/β-catenin signaling was not affected in Bmp4cko foregut. 
In contrast to Wnt/β-catenin signaling, we detected consistent reduction of Shh 
expression level in Bmp4cko foregut, suggesting that Bmp4 may regulate tracheal 
outgrowth via Shh. Shh has been implicated in the regulation of cell cycle genes such as 
Cyclins and we found that Cyclin D1 level was reduced in the epithelium and more 
pronounced reduction in the mesenchyme of Bmp4cko foregut. It has been shown that in 
most tissues the D-type cyclins are largely exchangeable; when two of the three D-cyclins 
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are ablated, the remaining cyclin will be ubiquitously upregulated to compensate for the 
loss (Ciemerych, Kenney et al. 2002). However, we did not find upregulation of Cyclin 
D2 and D3 to compensate for the Cyclin D1 reduction, indicating reduced cell 
proliferation in Bmp4cko is at least in part due to attenuated Cyclin D1 expression.  
The Bmp4-deficient foregut showed impaired cell proliferation, without apparent 
alteration in cell death, whereas embryos with loss of Shh displayed severe 
esophagotracheal defects with reduced cell proliferation and elevated cell death  
(Litingtung, Lei et al. 1998; Pepicelli, Lewis et al. 1998; and Y.L. and C.C., unpublished 
observation). The difference between these two mutants suggests that low levels of Shh 
may be sufficient for cell survival while high levels of Shh may be required to promote 
cell proliferation.  
While our data together with several other previous reports (Chen, Bei et al. 1996; 
Zhang, Zhang et al. 2000; Zhang, Song et al. 2002) suggest that Bmp4 acts upstream of 
Shh, it also appears that Shh signaling can conversely regulate the expression of Bmp4 in 
the developing lung mesenchyme (Litingtung, Lei et al. 1998; Pepicelli, Lewis et al. 1998; 
Weaver, Batts et al. 2003). Hence, these two highly conserved and ubiquitous signaling 
systems, Bmp and Shh, might cross-regulate each other during embryogenesis in 
promoting tissue outgrowth and patterning. 
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CHAPTER IV 
 
GENERAL DISCUSSION 
Development of the dorsal esophagus and the ventral trachea from a common 
anterior foregut endoderm is a complex process involving cell proliferation, programmed 
cell death, differentiation and migration, which requires appropriate and regulated 
interactions between two different interfaces, not only within the foregut tissue but 
between foregut and its adjacent tissues as well. In this dissertation work, I have focused 
on Bmp signaling and its role during anterior foregut patterning. Our studies have 
identified a pathogenic role of deregulated Bmp signaling resulting from loss of the Bmp 
antagonist Noggin in the formation of esophageal atresia, which involves inappropriately 
prolonged interaction between the foregut endoderm and the overlying notochord. In 
addition, we have elucidated an instructive/permissive role for mesodermally derived 
Bmp4 during tracheal outgrowth; this involves Bmp4-mediated reciprocal 
communications between tracheal foregut endoderm and mesoderm. Ablation of this 
Bmp4 function resulted in tracheal loss, a foregut malformation that has not been 
previously demonstrated in genetic mouse models. My work therefore sheds new insights 
into the relatively under-explored research area involving morphogenesis of the trachea 
and esophagus, and brings up interesting new questions that need to be addressed in the 
future. 
 
109 
Identification of new animal models with foregut anomalies 
Our investigation of the role of Bmp signaling in anterior foregut patterning has 
revealed two new mouse models manifesting human foregut malformations. As 
mentioned in the introduction, several mouse mutant lines previously generated, such as 
Shh-/-, Gli2-/-Gli3+/- and Nkx2.1-/-, show foregut defects (Table 1.2); however, they do not 
exhibit the typical phenotype of the most common form of EA/TEF, Type C, in which the 
upper esophagus ends in a blind pouch and the lower esophagus, normally stenosed, 
abnormally connects to the trachea via a fistula (Table 1.1). We found that mouse 
embryos lacking Noggin, a Bmp antagonist, displayed foregut defects that are highly 
reminiscent of Type C EA/TEF (Figure 2.1), thus providing genetic evidence linking 
deregulated Bmp signaling in the pathogenesis of the most prevalent form of EA/TEF. 
Tracheal atresia/agenesis (TA) is relatively rare (less than 1:50,000) but nevertheless 
represents a life-threatening malformation that produces respiratory distress due to partial 
or complete absence of the trachea (Manschot, van den Anker et al. 1994). So far, no one 
has reported genetic mouse models exhibiting TA. We identified that ablation of Bmp4 in 
the ventral foregut domain by Foxg1Cre resulted in complete loss of trachea, therefore 
providing the first genetic mouse model representing the human TA condition. This 
finding suggests that insufficient Bmp signaling during tracheal morphogenesis is linked 
to the pathogenesis of TA.  
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Noggin-mediated Bmp antagonism in the pathogenesis of esophageal atresia 
Our results indicate that the esophageal atresia in Nog-/- embryos (E11.5 and 
E10.5, Figure 2.2) correlate with a specific dorsal foregut endoderm reduction (Figure 2.1 
and 2.2). Dorsal foregut defects in Nog-/- embryos appear to associate with abnormal 
notochord branches making contact with the dorsal foregut in Nog-/- embryos, similar to 
those reported in the adriamycin-induced rat embryos (Possoegel, Diez-Pardo et al. 1999; 
Qi and Beasley 1999; Orford, Manglick et al. 2001; Qi, Beasley et al. 2001; Williams, Qi 
et al. 2001; Mortell, O'Donnell et al. 2004). Consistent with our hypothesis that impresice 
detachment of notochord due to its prolonged contact with the dorsal foregut may 
contribute to the dorsal foregut endoderm loss, we found loosening or loss of cells in the 
dorsal foregut endoderm (Figure 2.7), and the presence of non-notochordal (T-/Foxa2+ 
and sox9-), likely foregut endodermal cells in the Nog-/- notochord, amongst notochord 
cells (Figure 2.6). Since the dorsal foregut endoderm is composed of only a few cells at 
E8.5-9.0 (Figure 2.2 E-L), it is conceivable that loss of just a few dorsal endodermal cells 
during notochord detachment can result in significant reduced dorsal foregut domain at 
later stages. While it remains possible that T- or Sox9- cells in Nog-/- notochord may 
represent a subpopulation of aberrant notochord cells that failed to express these markers, 
it is unlikely that these cells would display selective loss of T or Sox9 expression but not 
Foxa2 expression. This notion argues in favor of the presence of endodermal cells that are 
Foxa2+but T- within the Nog-/- notochord. Ideally, lineage tracing of dorsal foregut 
endoderm cells in Nog-/- mutants should be performed; however, so far no dorsal foregut 
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endoderm-specific gene promoter has been identified. In addition, we have not revealed 
any markers that are dorsal foregut endoderm specific, likely due to a common 
mesendodermal origin of the dorsal foregut and the notochord during gastrulation (Kinder, 
Tsang et al. 2001).  
Our data imply a new role of Noggin-mediated Bmp antagonism in dorsal foregut 
development and in the pathogenesis of EA/TEF. Under physiological condition, Noggin 
is required to keep Bmp signaling silent in the notochord so it can properly detach from 
the dorsal foregut endoderm in a timely manner; in the absence of Noggin, elevated Bmp 
signaling in the notochord results in its prolonged attachment to the roof of the dorsal 
foregut endoderm, which contribute to dorsal foregut cell loss (Figure 2.12). We have not 
yet identified the molecular activity downstream of deregulated Bmp signaling that 
results in delay and improper notochord delamination in our current study; however, we 
think it is likely associated with perturbation of cell-cell interaction between notochord 
and the foregut endoderm since disruption of the basement membrane is obvious in Nog-/- 
embryos (Figure 2.2 and 2.7). The mechanism underlying the establishment of the 
cellular boundary between the roof of the foregut endoderm and notochord remains to be 
elucidated. 
In our study, we show that ablating Bmp7 completely rescued the EA/TEF and 
foregut endoderm reduction observed in Nog-/- embryos (Figure 2.9). Since other Bmps, 
such as Bmp4 secreted from the ventral foregut mesoderm, may also contribute to an 
increase in Bmp signaling in the notochord, we can not rule the possibility that other 
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Bmps may also be involved.  Consistent with this notion, during the course of this work, 
another group also reported a similar phenotype using Noggin mutant mice (Que, Choi et 
al. 2006). In their study, they rescued the EA/TEF defect by partial removal of Bmp4, 
which is normally present in the ventral foregut mesoderm. The successful rescue of Nog-
/- EA/TEF by two different Bmps suggests that Bmps expressed in overlapping domains 
may exhibit functional redundancies during development. In contrast, embryos with loss 
of Chordin (Chrd-/-), another Bmp antagonist that shares several overlapping functions 
with Noggin (Bachiller, Klingensmith et al. 2000), displayed a fairly normal esophagus 
and trachea (Figure 2.11), indicating a distinct function of Noggin in proper notochord 
detachment. 
To further explore the critical role of Noggin-mediated antagonism in EA/TEF 
pathogenesis that we established in the mouse model, we collaborated with Dr. Harold 
Lovvorn to perform a genetic screening of 50 patients with EA/TEF for point mutations 
within the human NOG coding region. Although we did not identify any point mutation, 
except a conservative polymorphism in one patient, it is possible that it is in part due to 
the relatively small sample size. In addition, we have not examined potential mutations in 
the promoter region, so it remains possible that NOG gene could be misregulated 
(suppressed) in some of these patients due to aberrant gene promoter activity. Another 
plausible explanation is that most of EA/TEF cases may be the result of misregulated 
Bmp signaling caused by environmental influences, such as exposure to certain 
teratogenic drugs or presence of a disease condition, other than genetic inheritance. This 
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is supported by the fact that familial occurrence of the congenital defect with associated 
anomalies is not common (Auchterlonie and White 1982; McMullen, Karnes et al. 1996; 
Nezarati and McLeod 1999).    
   
The role of Bmp signaling in tracheal formation 
Our results from the Bmp4cko foregut study suggest a critical role of signaling by 
Bmp4 produced in the ventral foregut mesoderm in the regulation of tracheal growth. In 
the Bmp4cko embryos, Bmp4 in the ventral foregut is selectively deleted with Foxg1Cre, 
which results in complete loss of the trachea, evident at E11.5 and E10.5 (Figure 3.6). 
Consistent with a reduction in growth potential, Bmp4cko embryos display reduced cell 
proliferation in the foregut endoderm as well as the mesoderm (E9.5, Figure 3.9). 
However, the presence of Nkx2.1-positive cells in the endoderm of Bmp4cko embryos at 
E9.0, a stage prior to the appearance of respiratory primordium, suggests that Bmp4-
mediated signaling is required for the subsequent outgrowth but not the initial 
specification of the tracheal primordium. This newly identified Bmp signaling role is 
different from the role of Bmps in liver development, in which Bmp signaling appears to 
be essential both for initial hepatic fate specification and subsequent outgrowth of hepatic 
endoderm into liver buds (Zaret 2000; Rossi, Dunn et al. 2001; Zaret 2001).  
Similar to morphogenesis of other organs such as lung, kidney and pancreas, 
tracheal development is also controlled by a complex process of inductive interactions 
between the endoderm and its surrounding mesoderm. We observe reduction in Bmp 
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signaling in both the ventral foregut endoderm and mesenchyme in the Bmp4cko foregut 
(Figure 3.4); therefore, it is conceivable that mesenchymally-derived Bmp4 signals in 
both paracrine and autocrine fashions to respectively regulate the underlying foregut 
endoderm growth and affect mesenchymal cells to secrete growth factors or ECM 
molecules which are important for mesenchymal-epithelial interaction, epithelial growth 
and patterning. Consistent with this notion, we detect that expression levels of Shh in the 
ventral endoderm are significantly reduced in the Bmp4cko foregut. Since Shh signals to 
both the mesoderm and the endoderm (Litingtung, Lei et al. 1998; Pepicelli, Lewis et al. 
1998; and Y.L. and C.C., unpublished observation), and it has been implicated in the 
regulation of cell proliferation (Kenney and Rowitch 2000; Berman, Karhadkar et al. 
2002; Ciemerych, Kenney et al. 2002; Mill, Mo et al. 2003; Yu, Mazerolle et al. 2006), 
the reduced Shh level is consistent with the observed reduction of cell proliferation in the 
Bmp4cko foregut endoderm and mesoderm.  
While the Bmp4-deficient foreguts display reduced cell proliferation, without 
apparent alteration in cell death, embryos with loss of Shh exhibit severe 
esophagotracheal defects with reduced cell proliferation and elevated cell death 
(Litingtung, Lei et al. 1998; Pepicelli, Lewis et al. 1998; and Y.L. and C.C., unpublished 
observation). The difference in cellular behaviors between these two mutants suggests 
that low levels of Shh may be necessary for cell survival while high levels of Shh are 
critical to promote cell proliferation.  
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Cross-regulation of signaling pathways 
Cross-regulation between signaling pathways is thought to be critical during the 
growth and patterning of many organ systems. The relationship between Bmp and Shh 
can be either opposing or promoting, depending on different developmental contexts. For 
instance, in the developing central nervous system, Shh (located ventrally in the 
notochord and floor plate) and BMP (located dorsally in the boundary of 
neural/nonneural ectoderm and later in the roof plate) functionally oppose each other to 
properly pattern the dorsoventral aspect of the neural tube (Jessell and Sanes 2000). 
Similarly, in the developing limb field, Bmp signaling derived from the mesoderm needs 
to be modulated by its antagonist Gremlin, which is essential to maintain the Shh-Fgf4 
feedback loop (Capdevila, Tsukui et al. 1999; Zuniga, Haramis et al. 1999; Khokha, Hsu 
et al. 2003).  In contrast to the antagonistic interaction, during palate and tooth germ 
development, mesenchymally- derived Bmp4 is thought to act upstream of Shh. Bmp4-
soaked bead can induce Shh expression in explant culture and transgenic expression of 
human BMP4 under the Msx1 promoter in Msx1-/- palatal mesenchyme restores Shh 
expression in the epithelium (Chen, Bei et al. 1996; Zhang, Zhang et al. 2000; Zhang, 
Song et al. 2002). Our analysis of Bmp4cko foregut also indicates that Bmp can upregulate 
Shh expression during tracheal outgrowth. While our data, together with previous reports 
(Chen, Bei et al. 1996; Zhang, Zhang et al. 2000; Zhang, Song et al. 2002), suggest that 
Bmp4 acts upstream of Shh, it also appears that Shh signaling can conversely regulate the 
expression of Bmp4, as in the developing lung mesenchyme (Litingtung, Lei et al. 1998; 
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Pepicelli, Lewis et al. 1998; Weaver, Batts et al. 2003). Hence, these two highly 
conserved signaling systems, Bmp and Shh, can cross-talk during embryogenesis to 
promote tissue outgrowth and patterning. 
 
FUTURE DIRECTIONS 
 
Molecular and cellular distinction of foregut endoderm and notochord 
Our results of the Nog-/- foregut, together with investigations in the adriamycin 
rat/mouse model (Possoegel, Diez-Pardo et al. 1999; Qi and Beasley 1999; Orford, 
Manglick et al. 2001; Qi, Beasley et al. 2001; Williams, Qi et al. 2001; Mortell, 
O'Donnell et al. 2004), implicate notochordal abnormalities in  the pathogenesis of 
esophageal atresia, suggesting the importance of proper notochord delamination to the 
integrity of the dorsal foregut, which in turn is critical for the subsequent development of 
the dorsal structure, the esophagus. While our study has shed light on the essential role of 
Noggin-mediated Bmp antagonism in the appropriate notochord detachment from the 
roof of the foregut, we have not identified factors that control this process which could be 
altered by deregulated Bmp signaling. We think it is likely associated with perturbation of 
cell-cell interaction between notochord and the foregut endoderm as disruption of 
basement membrane is evident in Nog-/- embryos (Figure 2.1 and Figure 2.7). How the 
boundary between the notochord and the underlying dorsal foregut is defined and how it 
is affected by Bmp signaling are important future questions. 
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During development, the notochord is initially embedded in the dorsal foregut 
hence physically participate in the formation of the roof of the primitive gut tube; 
however, these two types of tissues are already predetermined and therefore intrinsically 
different from each other. As development proceeds, the foregut endodermal cells and the 
notochordal cells detach and the latter move dorsally to lie underneath the neural tube. 
How the foregut endoderm is molecularly programmed to be distinguished from the 
notochord is still unknown. In the mouse, all the genes so far found that are expressed in 
the foregut endoderm are also expressed in the notochord, likely due to a common 
mesendodermal origin during gastrulation (Kinder, Tsang et al. 2001).  Recently, 
expression of Panza, a α2-macroglobulin (α2M), was found to be restricted to the dorsal 
domain of the primitive gut, but not the notochord, in Xenopus laevis (Pineda-Salgado, 
Craig et al. 2005). α2M is an abundant serum protein in vertebrates and arthropods with 
diverse functions, including inhibition of protease activity and binding of growth factors, 
cytokines, and disease factors (Borth 1992). It will be interesting to determine whether 
the mammalian counterpart is also selectively expressed in the endoderm. If so, this will 
provide some insight into how the transcriptional regulatory mechanism permits a foregut 
endoderm specific lineage expression. 
 
The role of Bmp receptors in tracheal morphogenesis 
Our study of conditional Bmp4-deficient foregut elucidates an essential role of 
Bmp signaling in tracheal outgrowth. There are three type I receptors, (BMPR-1A/Alk3, 
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BMPR-1B/Alk6 and ActR-I/Alk2), that bind and transduce signaling of Bmps. It is 
intriguing which type I receptor mediates Bmp signaling in tracheal outgrowth. While 
Alk6 normally is not highly expressed in the anterior foregut, Alk3 and Alk2 are expressed 
in the developing primitive foregut (Yoshikawa, Aota et al. 2000, and Y.L and C.C 
unpublished observation). Mice with targeted mutation of Alk6 are viable (Liu, Wilson et 
al. 2003), whereas those with mutations in Alk2 and Alk3 die before E9.5, exhibiting 
profound disruption in early embryonic development (Mishina, Suzuki et al. 1995; 
Mishina, Crombie et al. 1999). Taken together, it suggests that Bmp4 signaling in the 
ventral foregut is likely mediated via Alk3 or Alk2 or both. To decipher which receptor is 
involved in the Bmp4-mediated tracheal outgrowth, we could conditionally ablate Alk2 
and Alk3 in the foregut region with the same strategy as for the Bmp4 conditional 
ablation by Foxg1Cre. Homozygous mice for Alk3flox/flox and Alk2flox/flox have been 
generated, and are viable with no discernable phenotype (Kaartinen and Nagy 2001; 
Mishina, Hanks et al. 2002). Prior to obtaining Foxg1Cre transgene, I attempted to 
address this question by ablating Alk3 or Alk2 with ShhCre transgene. Shh expression is 
normally found in the ventral foregut endoderm (Litingtung, Lei et al. 1998; Pepicelli, 
Lewis et al. 1998); therefore, ShhCre will specifically delete receptors in the endoderm. 
The resulting conditional mutant foreguts revealed fairly normal formation of the 
esophagus and trachea, suggesting that deleting either receptor alone is not sufficient or 
endodermal Bmp4 signaling per se is not critical for tracheal outgrowth. To distinguish 
these two possibilities, we need to generate conditional mutants deficient for both 
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receptors by ShhCre. The comparison of mutants generated by Foxg1Cre and ShhCre will 
also provide us with new insights into whether paracrine (mesenchymal Bmp signaling to 
the endoderm) or autocrine (mesenchymal Bmp signaling to mesenchyme, which in turn 
affects the endoderm) or both is critical for tracheal morphogenesis, as Foxg1Cre deletes 
receptors in both layers whereas ShhCre only deletes receptors in the endoderm. 
 
Specification of the tracheal and esophageal primordium 
The Bmp4cko foregut that we have generated is so far the only mutant that exhibit 
complete loss of the trachea. Our analysis of this mutant foregut suggests that Bmp 
signaling is likely not required for the initial tracheal specification but rather the 
subsequent growth of the respiratory primordium, thus implying that other still 
unidentified signal(s) is required for tracheal specification. In addition to questions 
regarding specification of the trachea, it is also not clear how foregut cells adopt the 
esophageal fate and what signals are involved. A major limitation is the lack of markers 
specific for the trachea or esophagus. Laser capture microdissection is a recently 
developed method for procuring pure cells from specific microscopic regions of tissue 
sections, which may be a tool to enable us to identify specific markers for the esophagus 
and trachea. We could extract tracheal and esophageal primordia from foregut tissue 
sections by performing laser capture microdissection and compare their mRNA 
expression profiles. Genes that are differentially expressed may be useful as 
tracheal/esophageal specific markers. Armed with these newly identified markers, we 
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could carry out definitive experiments to uncover signals that are important for anterior 
foregut patterning.    
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CHAPTER V 
 
SONIC HEDGEHOG SIGNALING REGULATES GLI3 PROCESSING, 
MESENCHYMAL PROLIFERATION, AND DIFFERENTIATION DURING MOUSE 
LUNG MORPHOGENESIS 
 
Introduction 
Lung development involves a highly orchestrated series of growth and 
morphogenetic events, precisely regulated by complex interactions among signaling 
molecules and transcription factors (Whitsett 1998; Hogan 1999; Perl and Whitsett 1999; 
van Tuyl and Post 2000; Warburton, Schwarz et al. 2000; Cardoso 2001; Costa, 
Kalinichenko et al. 2001). Reports of lung abnormalities, both in humans and from mouse 
models, due to genetic aberrations, diseases and environmental factors abound in the 
literature. In severe cases, lung hypoplasia has also been shown concurrently with 
congenital diaphragmatic hernia (CDH) in humans, with an incidence of 1 in 2500 
newborns (Causak, Zgleszewski et al. 1998; Zhang, Zgleszewski et al. 1998; Chinoy, Chi 
et al. 2001; Chinoy 2003; Unger, Copland et al. 2003).  
The mammalian Gli gene family consists of three members, Gli1, Gli2 and Gli3 
(Kinzler, Ruppert et al. 1988; Ruppert, Kinzler et al. 1988; Hui, Slusarski et al. 1994), 
which encode zinc finger transcription factors involved in both developmental regulation 
and human diseases (Vortkamp, Gessler et al. 1991; Kang, Graham et al. 1997; Wild, 
Kalff-Suske et al. 1997; Ming, Roessler et al. 1998; Villavicencio, Walterhouse et al. 
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2000). All three Gli genes are expressed in the lung mesenchyme during the 
pseudoglandular stage of development (Grindley, Bellusci et al. 1997) and mutations in 
the Gli genes give rise to various lung and foregut defects (van Tuyl and Post 2000). 
While Gli1 is dispensable for lung development in the presence of other Gli genes (Park, 
Bai et al. 2000), Gli2-/- mutant lung exhibits right lobe hypoplasia, narrowing of the 
esophagus and trachea (Motoyama, Liu et al. 1998) and Gli3XtJ mutant lung, with an 
intragenic deletion of Gli3 (Vortkamp, Franz et al. 1992; Hui and Joyner 1993), shows an 
overall growth defect with a pronounced length reduction of the left lobe (Grindley, 
Bellusci et al. 1997). Compound mutants such as Gli2 and Gli3 null mice are severely 
defective in upper foregut structures lacking lung, trachea and esophagus. Gli2-/-;Gli3+/- 
foregut displays tracheoesophageal fistula (TEF) and severe lung growth and lobation 
defects (Motoyama, Liu et al. 1998). Likewise, Gli1 and Gli2 compound homozygous 
mutants show severe lung defects (Park, Bai et al. 2000). These findings point to the 
critical role of the Gli genes in the development of foregut structures.  
Shh is one among several important factors, derived from the lung endoderm, that 
is required for proliferation, differentiation and patterning of the mesenchyme and Shh 
null mice exhibit foregut anomalies including hypoplastic lungs due to defects in 
branching morphogenesis (Bellusci, Furuta et al. 1997; Litingtung, Lei et al. 1998; 
Pepicelli, Lewis et al. 1998).  Shh signaling has been implicated in the regulation of Gli 
genes (Ruiz 1999), notably Gli1 and Gli3 transcription in the lung (Litingtung, Lei et al. 
1998; Pepicelli, Lewis et al. 1998).  Gli2 has also been implicated in the regulation of 
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Ptch1 and Gli1 (Motoyama, Liu et al. 1998), components of the Shh signaling cascade in 
the lung, although Gli2 expression in the Shh-/- mutant lung mesenchyme is unaffected 
(Pepicelli, Lewis et al. 1998). It is possible that Gli2 activator function may be 
compromised in the absence of Shh signaling (Sasaki, Nishizaki et al. 1999; Mill, Mo et 
al. 2003). Shh signaling has also been shown to be activated in small cell lung cancer 
(SCLC) cell lines and cyclopamine, a hedgehog signaling antagonist, was shown to 
inhibit SCLC tumorigenicity (Watkins, Berman et al. 2003).  
Gli3 is a bipotential transcription factor (Motoyama, Liu et al. 1998; Dai, 
Akimaru et al. 1999; Sasaki, Nishizaki et al. 1999; Dai, Shinagawa et al. 2002) and it has 
been shown the repressor form of Gli3 (Gli3R), generated as a result of proteolytic 
cleavage and lacking amino acids C-terminal to the zinc finger domain, is activated in the 
absence of Shh signaling in the developing limbs (Wang, Fallon et al. 2000; Litingtung, 
Dahn et al. 2002). Gli3R has been implicated in the regulation of growth and patterning 
of the ventral spinal cord (Litingtung and Chiang 2000; Persson, Stamataki et al. 2002; 
Wijgerde, McMahon et al. 2002) and limb (Litingtung, Dahn et al. 2002; te Welscher, 
Zuniga et al. 2002). It appears that while abrogating Shh function alone results in serious 
developmental defects, absence of the Shh signal combined with a lack of Gli3 function 
can result in an apparently less severe phenotype.  
The effect of Shh signaling on Gli3 processing has been examined mainly in 
tissues known to be exposed to a long-range Shh gradient. However, it is not clear 
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whether Shh similarly regulates Gli3 processing in the lung. Furthermore, to what extent 
Shh-regulated Gli3 processing plays a role in lung development has not been addressed.  
Our findings shed light on the important role of Shh signaling on Gli3 processing and its 
role in proliferation and differentiation during lung growth and patterning, by directly or 
indirectly regulating the expression of critical developmental genes.  
 
125 
Material and Methods 
Embryos  
The generation and identification of Shh and Gli3 mutant embryos and mice were 
performed as previously described (Litingtung and Chiang 2000). 
 
Lung organ culture and Western blotting 
The lung culture method used (Litingtung, Lei et al. 1998), production of amino-
terminal-specific Gli3 (Gli3-N) antibody and Western analysis were performed 
essentially as previously described (Litingtung, Dahn et al. 2002). E11.5 wildtype (WT) 
lungs were cultured with cyclopamine (gift of W. Gaffield) in serum-free culture medium 
at a final concentration of 4 μg/ml for 24 hours, after which lung lysates were collected 
and resolved on 7.5% SDS-polyacrylamide gel, loading 150 μg total protein per lane. 
Lung lysates were also prepared from freshly dissected E12.5 WT and Shh-/- lungs and 
analysed by Western blotting with antibodies against Gli3-N, Cyclin D1 (BD Pharmingen, 
1:250 dilution) or Cyclin E (Santa Cruz, 1:500 dilution).  
 
Analysis of cell proliferation  
5-bromodeoxyuridine (BrdU) in vivo labeling and detection were performed as 
previously described (Litingtung, Lei et al. 1998) (also see Chapter II). Cells in five 
different photomicrographs representing random portions of the WT, Shh-/- or Shh-/;Gli3-/- 
lungs were counted. The total number of epithelial cells counted were 1363, 1915 and 
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1900 and the total mesenchymal cells counted were 3911, 2734 and 3126, in WT, Shh-/- 
and Shh-/-;Gli3-/- , respectively. Statistic analysis was performed as described in Chapter 
III. 
 
In situ hybridization 
Whole-mount and cryosection in situ hybridizations were performed as previously 
described (Litingtung, Lei et al. 1998). The following cDNAs were used as templates for 
synthesizing digoxygenin-labeled riboprobes: Ptch1 (Goodrich, Johnson et al. 1996), 
Gli1 (Hui, Slusarski et al. 1994), Wnt2 (Huguet, McMahon et al. 1994), Foxf1 
(Kalinichenko, Lim et al. 2001), Tbx2, Tbx3, Tbx4, Tbx5 (Chapman, Garvey et al. 1996), 
c-myc and N-myc (Serra and Moses 1995). 
 
Immunohistochemistry 
Whole-mount staining was performed on E12.5 and E13.5 embryos using anti-
Hnf-3β antibody (kindly provided by B. Hogan) as described (Litingtung, Lei et al. 1998). 
Labelings using antibodies against Cyclins D1, D2 and D3 were performed on 5μm tissue 
sections from paraffin-embedded embryos fixed in 4% paraformaldehyde overnight at 
4oC. Paraffin sections were deparaffinized and rehydrated according to standard protocols. 
Endogenous peroxidase activity was blocked using 3% H2O2 in methanol for 10 minutes 
at room temperature. To reveal Cyclins D1, D2 and D3, sections were antigen-retrieved 
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using the DAKO target retrieval solution (pH 6.1), following DAKO’s suggested protocol 
using a Black & Decker Handy Steamer. The antibodies used were: mouse anti-human 
Cyclin D1 (BD Pharmingen, 1:100 dilution); Cyclin D2 (Santa Cruz, 1:200 dilution); 
Cyclin D3 (Neomarkers, 1:200 dilution). For signal enhancement, a goat anti-mouse IgG-
HRP or goat anti-rabbit IgG-AP polymer conjugated secondary antibody from ZYMED 
Picture-Double staining kit was used, following the company’s suggested protocol. For 
studies on differentiation, E15.5 cryosections collected from embryos fixed in 4% 
paraformaldehyde for 4 hours at 4oC were used for immunolabelings: sections were 
blocked in 10% goat serum in PBS containing 0.1% triton-X 100 at room temperature for 
1 hour to reduce non-specific staining, followed by an overnight incubation at 4oC with 
the following primary antibodies: rat anti-mouse PECAM-1/CD31 (BD Pharmingen, 
clone MEC 13.3, 1:100 dilution); rat anti-Flk-1 (BD Pharmingen, 1:50 dilution); mouse 
anti-Smooth Muscle Alpha-Actin (SMA) (Sigma, clone 1A4, 1:300 dilution); rabbit anti-
Smooth Muscle Myosin II Heavy Chain (SMM) (BioMedical Technologies, 1:150 
dilution). Sections were washed with several rinses of PBS containing 0.1% Tween-20 
(Sigma). Alexa 488 (green)- or Alexa 568 (red)-conjugated secondary antibodies 
(Molecular Probes) were applied at 1:600 dilutions for 1 hour at room temperature.  
 
RNA extraction, reverse transcription and Real-Time PCR 
Total RNA was extracted from E12.5 WT and Shh -/- lungs using the RNeasy Mini 
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kit (Qiagen). cDNA was synthesized from 1 μg of total RNA with 4 units of Omniscript 
reverse transcriptase (RT) (Qiagen) in 20 μl, using 0.5 μg random hexamer primers 
(Invitrogen) according to the manufacturer’s instructions. PCR was performed using 20 
μl of a 1:10 dilution of a specific cDNA to confirm a single product with the desired 
length. Real-time PCR was performed in the iCycler Iq detection system (Bio-Rad): each 
reaction contained 25 μl of the 2X Quantitect SYBR Green (Qiagen) PCR Master Mix, 3 
μl forward primer-f (5 μM), 3 ul reverse primer-r (5 μM), 5 μl of a 1:10 dilution of a 
specific wildtype or Shh-/- cDNA and 14 μl H2O. PCR conditions: enzyme activation 
program (95°C for 15 min), amplification and quantification program repeated 45 times 
(94°C for 15 s, 58°C for 30 s, 72°C for 30 s) and melting curve program (55-95°C with a 
heating rate of 0.025°C/s). PCR primers, spanning two exons, are listed below followed 
by PCR product size (bp):  
GAPDH:(f)5′-TTCACCACCATGGAGAAGGC-3′; 
               (r)5′-GGCATGGACTGTGGTCATGA-3′; 236. 
Wnt2b:   (f)5′-CACCCGGACTGATCTTGTCT3′; 
               (r)5′-GCCACAACACATGATTTCACA3′;142. 
Wnt5a:   (f)5′-AATCCACGCTAAGGGTTCCT-3′; 
               (r)5′-GAGCCAGACACTCCATGACA-3′;128. 
Wnt2:      (f)5-′GCAACACCCTGGACAGAGAT-3′; 
               (r)5′-ACAACGCCAGCTGAAGAGAT-3′;103. 
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Results and Discussion 
 
 Shh-/-;Gli3-/- lung exhibits increased growth compared with Shh-/- lung 
Gross morphological analyses of E12.5, E13.5 Shh-/-;Gli3-/- double mutant lungs 
(Figure 5.1) by whole-mount immunolabeling with an antibody against Hnf-3β,  an 
endodermal marker (Yasui, Sasaki et al. 1997), and E15.5 Shh-/-;Gli3-/- lung sections by 
hematoxylin and eosin (H&E) staining (Figure 5.1), reveal that the Shh-/-;Gli3-/- lungs 
show increased growth compared with age-matched Shh-/- lungs but patterning defects 
persist (Figure 5.1, 5.5, 5.6). There appears to be more epithelial buds with smaller 
lumens and a denser mesenchyme as shown in the E15.5 H&E-stained Shh-/-; Gli3-/- 
sections than in E15.5 Shh-/- sections (Figure 5.1 g-i). Our finding that absence of Gli3 
function in Shh-/-;Gli3-/- lungs yields a mutant lung with enhanced growth potential 
compared with the Shh-/- lungs, demonstrates the interplay between Shh and Gli3 
functions is conserved in the lung as in the limb and ventral neural tube. Albeit, the 
partial rescue in growth with persistent patterning defects in Shh-/-;Gli3-/- lung (Figure 5.1, 
5.5, 5.6) suggests there is a strict requirement for Shh (Litingtung, Lei et al. 1998; 
Pepicelli, Lewis et al. 1998) and Gli3 (Grindley, Bellusci et al. 1997; Motoyama, Liu et al. 
1998) functions during lung development. Based on previous observations in the neural 
tube (Litingtung and Chiang 2000) and limb (Litingtung, Dahn et al. 2002)( (te Welscher, 
Zuniga et al. 2002), it is postulated that the repressor form of Gli3 (Gli3R), which is 
generated at a higher level in the absence of Shh signaling, may contribute to growth 
130 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.1 Morphology of Shh−/−;Gli3−/− lung compared with Shh−/− and WT lungs. 
Foxa2 immunostaining of WT, Shh−/−, and Shh−/−;Gli3−/− E12.5 (a–c) and E13.5 (d–f) 
lungs, showing less severe hypoplasia of the Shh−/−;Gli3−/− lungs (c,f) compared with 
Shh−/− (b,e) lungs. Hematoxylin and eosin staining of E15.5 WT, Shh−/−, and 
Shh−/−;Gli3−/− lung tissue sections (g–i). There appears to be more epithelial (epi) buds 
(c,f,i) with smaller lumen (i) and a more compact mesenchyme (mes) (i) in Shh−/−;Gli3−/− 
compared with Shh−/− lungs (b,e,h). Magnification 400X for panels a–f and 200Xfor 
panels g–i. 
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 suppression. Hence, one interpretation is that removing Gli3R, essentially by deleting 
Gli3, could enhance the growth potential of the Shh-/- lung, as has been observed in other 
organ systems, emphasizing the conserved role of Gli3R in growth regulation. Shh 
signaling, based on Gli1 and Ptch1 expressions, is not restored in the Shh-/-;Gli3-/- double 
mutant lung (Figure 5.6 c,f). This initial finding suggests while lack of Shh signaling 
leads to severe lung hypoplasia, genetically deleting Gli3 from the Shh-/- lung, hence 
abrogating Gli3R function, appears to have a positive effect on the overall growth of the 
resulting Shh-/-; Gli3-/- double mutant lung.  
 
Gli3R level is higher in Shh-/- lung in vivo and in wildtype cyclopamine-treated lung 
in culture 
By Western analysis of freshly dissected E12.5 WT and Shh-/- lungs, we show that 
Shh-/- lungs exhibit higher levels of Gli3R compared with wildtype, with a concomitant 
decrease in the level of full length Gli3 (Gli3-190) (Figure 5.2A, lanes 1 and 2). The 
observation that a low level of Gli3R is normally present in wildtype lungs (Figure 5.2A, 
lane 2) suggests that the relative balance of Gli3R and full-length Gli3 may be important 
for normal lung development. This result is consistent with in vivo findings in the limb 
whereby a gradient of Gli3 processing exists across the limb bud, with the highest level 
of Gli3R in the anterior domain, furthest from the source of Shh which emanates from the 
posterior margin (Wang, Fallon et al. 2000; Litingtung, Dahn et al. 2002). Cyclopamine, a 
plant-derived steroidal alkaloid, has been shown in several studies to downregulate Shh 
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signaling (Cooper, Porter et al. 1998; Incardona, Gaffield et al. 1998; Chiang, Swan et al. 
1999), by direct binding to Smoothened (Smo) (Chen, Taipale et al. 2002), a receptor that 
mediates Hedgehog signaling. Here, we show that cyclopamine treatment of E11.5 
wildtype mouse lungs results in dissociation of mesenchymal cells from the epithelium 
(Figure 5.2B-b, arrows) and elevated levels of Gli3R (Figure 5.2C, compare lanes 1 and 
2), consistent with the in vivo finding that Shh-/- lung contains higher levels of Gli3R 
(Figure 5.2A, lane 1), suggesting blockade in Shh signaling promotes Gli3 processing in 
the developing lung. As a control for the different species of Gli3 observed, we loaded 
protein lysates from Gli3-/- embryos which, as expected, did not show Gli3-specific 
protein bands (Figure 5.2A, lane 3).  
 
Shh-/-;Gli3-/- mesenchyme shows increased proliferation in vivo 
To further investigate the increase in growth potential of the Shh-/-;Gli3-/- lung 
compared with Shh-/- lung (Figure 5.1), we determined the proliferative capacity of WT 
and mutant lungs by in vivo labeling with bromodeoxyuridine (BrdU), a nucleotide 
analog that is incorporated into replicating DNA. BrdU pulse-labeling revealed a 
relatively higher percentage of proliferating mesenchymal cells in the Shh-/-;Gli3-/- lung 
(43.9%) compared with the Shh-/- mutant (35.8%) (Figure 5.3), suggesting the increased 
Gli3R level in the Shh-/- lung mesenchyme (Figure 5.2A, lane 1) contributes, at least in 
part, to its lower proliferative capacity. The Shh-/-;Gli3-/- lung epithelium also displayed a 
higher proliferative capacity (51.3%) compared with the Shh-/- epithelium (47.7%)  
133 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.2 Shh signaling regulates Gli3 processing in the mouse lung. 
(A) Protein extracts from freshly dissected E12.5 WT lungs (lane 2), Shh−/− lungs (lane 1), 
and Gli3−/− embryos (lane 3) were immunoblotted and probed with Gli3-specific antibody 
recognizing a prominent 190K band and several 83K to 86K bands, corresponding to full-
length (Gli3-190) and processed repressor forms (Gli3R) of Gli3, respectively. Note 
Shh−/− lungs (lane 1) contain a higher level of Gli3R, with a corresponding reduction in 
Gli3-190, relative to WT lungs (lane 2). The Gli3 antibody recognizes several nonspecific 
proteins (asterisks). Gli3−/− embryo extracts were used as a control for the absence of 
Gli3-specific bands. (B) E11.5 WT lungs were treated with cyclopamine, a Shh signaling 
antagonist, at a final concentration of 4 μg/ml in serum-free lung medium for 48 h. The 
cyclopamine-treated lung (b) shows less epithelial branching and loosening of the 
mesenchymal tissue (arrows and inset) compared with control lung with no cyclopamine 
(a). Magnification 500X for a,b. (C) Protein extracts from E11.5 WT lungs, untreated 
(lane 1) or treated (lane 2) with cyclopamine, as described above, and cultured for 30 h, 
were immunoblotted and probed with Gli3-specific antibody. 
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(Figure 5.3). Gli3R has been shown to preferentially accumulate in the nucleus of 
expressing cells (Dai, Akimaru et al. 1999; Wang, Fallon et al. 2000), hence, it is 
anticipated that Gli3R could exert its effects by affecting the transcription of target genes 
related to growth and differentiation. 
 
Cyclin D1 level appears downregulated in Shh-/- and derepressed in Shh-/-;Gli3-/- 
lungs while Cyclins D2,  D3 and myc levels remain unaltered 
The Shh signaling pathway has been implicated in the regulation of pro-
proliferative genes such as myc and Cyclins but whether their expressions are affected in 
the Shh-/- lung, and whether Gli3R plays a role, have not been documented. Cyclins and 
cyclin-dependent kinases (CDKs) are evolutionarily conserved proteins that are essential 
for cell cycle control in eukaryotes. Cyclin-CDK holoenzyme complexes such as Cyclin 
D-CDK4/6 and Cyclin E/CDK2 regulate G1/S cell cycle transitions. The activities of 
CDKs are also negatively regulated by specific CDK inhibitors (Sherr 1993; Nurse 1994; 
Sherr and Roberts 1999) (Miller and Cross 2001) ((Ekholm and Reed 2000). Numerous 
reports implicate Shh signaling in cell cycle regulation: the mitogenic effect of Shh 
during hair follicle development was found to be mediated by Gli2 activator which 
functions to upregulate Cyclins D1 and D2 (Mill, Mo et al. 2003); Shh opposes epithelial 
cell cycle arrest and promotes epidermal hyperplasia (Fan and Khavari 1999); N-myc and 
Cyclins D1 and D2 were found to be upregulated by Shh signaling in the proliferation of 
cerebellar granule neuron precursors in culture (Kenney and Rowitch 2000; Ciemerych,  
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Figure5.3 Shh−/−;Gli3−/− lung displays more cells at S phase compared with Shh−/− by 
in vivo BrdU pulse-labeling.  
Histogram showing the percentage of BrdU-labeled cells in the epithelium and 
mesenchyme of E13.5 Shh−/−;Gli3−/− lungs compared with Shh−/− and WT control. 
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Kenney et al. 2002; Kenney, Cole et al. 2003); Cyclopamine has been shown to block 
proliferation and downregulate myc and Cyclins D1, D2, E1 expression in a murine 
medulloblastoma cell line, implicating Shh signaling in regulating the expression of these 
genes, either directly or indirectly (Berman, Karhadkar et al. 2002); Cyclin D2 was 
identified as a target gene in Gli1-induced cellular transformation (Yoon, Kita et al. 2002) 
and overexpressing Shh in the developing lung leads to enhanced epithelial and 
mesenchymal cell proliferation (Bellusci, Furuta et al. 1997). The function of another 
mammalian hedgehog protein, Indian hedgehog (Ihh), has also been linked to 
chondrocyte proliferation during endochondral skeleton development and Cyclin D1 
upregulation (Long, Zhang et al. 2001). Moreover, Drosophila Hedgehog (Hh) has been 
implicated in the control of cell growth and proliferation during eye development, by 
promoting the transcription of Cyclins D and E (Duman-Scheel, Weng et al. 2002).  
The E-type cyclins partner with CDK2 and function during progression of 
mammalian cells through the G1/S phase. They show high expression patterns in many 
tissues such as the brain and lung during periods of active proliferation in the developing 
mouse embryo (Geng, Yu et al. 2001). Cyclin E level does not appear to be altered in  
Shh-/- lung compared with WT (Figure 5.4B); however, since the Western analysis 
represents overall expression of Cyclin E in whole lungs, we cannot rule out the 
possibility that Cyclin E may be expressed at lower levels in the wildtype lung 
mesenchyme compared with the epithelium, therefore, its decreased expression in Shh-/- 
lung mesenchyme could be masked by a higher unaltered level of Cyclin E expression in 
137 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.4 Expression of cyclin E and D-type cyclins in WT and mutant lungs.       
(A) Immunohistochemical labeling of E13.5 WT, Shh−/−, and Shh−/−;Gli3−/− lungs with 
Cyclin D1 (a–c), D2 (d–f), or D3 (g–i) antibodies. Cyclin D1 is expressed in both the 
epithelial (arrow) and mesenchymal (arrowheads) compartments of the developing lung. 
The bronchial smooth muscle is indicated by a red arrowhead. Expression of Cyclin D1 
in the epithelium (epi) is higher than in the mesenchyme (mes). Expression of Cyclin D1 
in Shh−/− lung is clearly downregulated in both epi and mes compartments and appears to 
be enhanced in the Shh−/−;Gli3−/− lung (c), compared with Shh−/− lung (b). Cyclins D2 and 
D3 show higher expressions in the proximal epithelium, lower levels distally and 
throughout the mesenchyme in all three genotypes. High mesothelial expression of cyclin 
D3 is also evident (arrowheads in g–i). (B) Western blot analysis of E12.5 WT and Shh−/− 
lungs, probed with antibodies against Cyclins D1 and E, showing downregulation of 
Cyclin D1 but no significant alteration in Cyclin E expressions in the Shh−/− 
lungcompared to WT lung; α-tubulin was used as a control for loading. Magnification 
100X for panel A. 
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the Shh-/- lung epithelium. To resolve this issue, we tested Cyclin E antibodies, from 
several sources, by immunohistochemistry on cryosections and antigen-retrieved paraffin 
sections, but failed to obtain positive staining indicating these Cyclin E antibodies were 
not suitable for tissue sections. In contrast, we found an overall reduction in the 
expression level of Cyclin D1, required for G1 progression (Quelle, Ashmun et al. 1993), 
in the E12.5 Shh-/- lung compared with WT lung by Western blot (Figure 5.4B). By  
immunohistochemistry, the decrease in Cyclin D1 expression was found in both the 
E13.5 Shh-/- lung epithelium and mesenchyme (Figure 5.4A-b), compared with WT lung 
which expresses Cyclin D1 in both epithelium (arrow) and mesenchyme (arrowheads) 
(Figure 5.4A-a). The expression of Cyclin D1 is strikingly higher in the lung epithelium 
than the mesenchyme (Figure 5.4A-a), consistent with the notion that proliferation is 
important for expansion of the lung epithelium during branching morphogenesis, 
although bud outgrowth per se does not appear to require localized cell proliferation 
(Nogawa, Morita et al. 1998). The bronchial smooth muscle (Figure 5.4A-a, red 
arrowhead) also shows detectable Cyclin D1 staining. The expression level and 
distribution of Cyclin D1 appear to be elevated in both the epithelium and mesenchyme 
of Shh-/-;Gli3-/- lung (Figure 5.4A-c), compared with Shh-/- (Figure 5.4A-b). These 
findings are consistent with the proliferative defects observed in Shh-/- lung and partial 
recovery of epithelial and mesenchymal proliferation in Shh-/-;Gli3-/- (Figure 5.3), 
implicating Shh signaling, directly or indirectly, in the regulation of Cyclin D1 in the lung, 
as confirmed by Western analysis (Figure 5.4B). Since Cyclin D1 has also been identified 
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as a key transcriptional target of Wnt-β-catenin signaling (Morin 1999; Shtutman, 
Zhurinsky et al. 1999; Tetsu and McCormick 1999; Behrens 2000), which is operative 
during lung development (Tebar, Destree et al. 2001; Shu, Jiang et al. 2002; Mucenski, 
Wert et al. 2003), it is difficult to discern if alterations in Cyclin D1 expression observed 
in Shh-/- lung (Figure 5.4A-b and Figure 5.4B) are a direct consequence of lack of Shh 
signaling or indirectly due to aberrant canonical Wnt signaling. Other pathways have also 
been linked to Cyclin D1 transcriptional activation (Hu, Lee et al. 2001; Zhao, Pestell et 
al. 2001).  Moreover, it is likely that the epithelial expression of Cyclin D1 (Figure 5.4A, 
a-c) is not regulated directly by Shh signaling since its targets, Ptch1 and Gli1, are not 
normally expressed in the lung epithelium. Hence, it is plausible to suggest that lung 
epithelial Cyclin D1 expression is under the control of a mesenchymally-derived signal 
which appears to be affected in the Shh-/- but upregulated in the Shh-/-;Gli3-/- lung. The 
Drosophila counterpart of vertebrate Gli proteins, Cubitus interuptus (Ci), which 
mediates Hh signaling, was shown to bind to the Cyclin E promoter in mediating 
transcriptional activation of the gene. Overexpression of Ci induces G1-arrested cells to 
progress through S-phase (Duman-Scheel, Weng et al. 2002). Whether Shh signaling 
directly regulates the expression of Cyclin D1, via Gli activation, in the mesenchyme 
remains to be determined.    
We also examined the expression of other D-type cyclins, namely Cyclin D2 and 
D3 (Figure 5.4A d-f and g-i). Cyclin D2 shows high expression in the E13.5 wildtype 
lung (Figure 5.4A-d), predominantly in the proximal epithelium (arrow) with lower levels 
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distally (arrowhead). Cyclin D2 is also expressed throughout the lung mesenchyme 
(Figure 5.4A-d), but was not observed in the more proximal regions around the bronchial 
smooth muscles, unlike Cyclin D1. The expression levels of Cyclin D2 in E13.5 Shh-/- 
and Shh-/-;Gli3-/- lungs seem comparable to wildtype and the proximal-distal differential 
distribution of Cyclin D2 in the epithelium is also maintained (Figure 5.4A-d-f). This 
finding suggests Shh signaling in the developing lung does not affect Cyclin D2 
expression, in contrast to its effect on Cyclin D1 expression. Myc has been shown to 
activate Cyclin D2 expression (Bouchard, Thieke et al. 1999; Perez-Roger, Kim et al. 
1999); likewise, loss of N-myc function in mice has been shown to disrupt Cyclin D2 
expression in the cerebellar primordium (Knoepfler, Cheng et al. 2002). In the mouse 
fetal lung, N-myc expression (Serra, Pelton et al. 1994; Serra and Moses 1995) is 
restricted to the bronchial epithelium while c-myc is expressed exclusively in the 
mesenchyme (Hirning, Schmid et al. 1991). Both N-myc and c-myc expression coincide 
with regions undergoing proliferation (Schmid, Schulz et al. 1989; Hirning, Schmid et al. 
1991). We did not observe significant alteration in the levels of N-myc or c-myc 
transcripts in E12.5 Shh-/- lung compared with WT, by in situ hybridization (Figure 5.5), 
suggesting that myc genes do not appear to play a significant role in the Shh-/- lung 
phenotype. This observation correlates with the finding that expression of Cyclin D2 is 
not altered in the Shh-/- lung (Figure 5.4A-e).  
Cyclin D3 shows distinct expression at the periphery of the lung (Figure 5.4A-g-i, 
arrowheads), along the visceral pleura which consists of squamous epithelium also 
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known as the mesothelium (Colvin, White et al. 2001; Weaver, Batts et al. 2003). Cyclin 
D3 is also expressed in the epithelium, more proximally like Cyclin D2, and uniformly 
throughout the mesenchyme of the E13.5 lung (Figure 5.4A-g). Its expression was also 
detected in the bronchial smooth muscle region lining the bronchial epithelium (Figure 
5.4A-g, arrow). The expression and distribution of Cyclin D3 in Shh-/- and Shh-/-;Gli3-/- 
lungs were comparable to WT lungs (Figure 5.4A, g-i), except for a lack of bronchial 
smooth muscle cells (see Figure 5.9). While all three D-type cyclins show overlapping 
expression domains, they also display unique expression patterns in the developing lung 
at E13.5 suggesting some of their functions may be distinct. Findings from previous 
studies suggest that the D-cyclins are largely exchangeable in most tissues and complete 
functional ablation of two of the three D-cyclins results in ubiquitous upregulation of the 
remaining intact cyclin during embryogenesis, apparently via a compensatory feedback 
loop, the precise mechanism of which has not been unraveled.  Hence, Cyclin D2-only 
mice displayed essentially normal development in most tissues (Ciemerych, Kenney et al. 
2002). However, lower levels of one cyclin such as Cyclin D1 in the Shh-/- lung (Figure 
5 .4A-b)  may not  necessar i ly  t r igger  the  ‘compensatory  feedback’ .  By 
immunohistochemistry, we did not observe compensatory upregulation of Cyclin D2 or 
D3 in the Shh-/- lung (Figure 5.4A-e,h). However, we cannot rule out the possibility that 
there could be minor changes in Cyclins D2 and D3 expression that cannot be detected by 
immunolabeling. Hence, the downregulation of Cyclin D1 in Shh-/- lung and its relative 
increase in Shh-/-;Gli3-/- could contribute, at least in part, to the proliferative defect and  
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Figure 5.5 c-myc and N-myc are not altered in Shh-/- lungs. 
Whole-mount in situ hybridization of WT and Shh-/- E12.5 lungs probed with c-myc (a, b) 
and N-myc (c, d). Magnification: 320X. 
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partial rescue in these mutant lungs, respectively. Certainly, the role of other cell cycle 
regulatory factors, such as CDKs, CDK inhibitors and tumor suppressors in the Shh-/- 
lung phenotype awaits further investigation. 
 
Wnt expression is not significantly altered in Shh-/- lung, except Wnt2, which is 
partially restored in Shh-/-;Gli3-/-  
Members of the Wnt gene family encode secreted glycoproteins that are involved 
in cell-cell interactions in tissue patterning and morphogenesis (Moon, Bowerman et al. 
2002; van Es, Barker et al. 2003), by activating different intracellular signaling cascades 
such as the Wnt-β-catenin pathway, upon interaction with the Frizzled family of receptors 
(Miller and Moon 1996; Yang-Snyder, Miller et al. 1996; Moon, Brown et al. 1997; Hsieh, 
Rattner et al. 1999; Kalderon 2002). Activation of canonical Wnt pathway results in 
stabilization of β-catenin and its translocation into the nucleus, where it complexes with 
HMG box transcription factors TCF/LEF (Galceran, Farinas et al. 1999), to induce 
transcription of target genes in promoting cell cycle progression (Behrens, von Kries et al. 
1996; Morin, Sparks et al. 1997; Eberhart and Argani 2001; Yokota, Nishizawa et al. 
2002). Several Wnts are expressed in the developing lung including mesenchymal Wnt2 
(Levay-Young and Navre 1992; Bellusci, Henderson et al. 1996), Wnt2b (Wnt13) (Zakin, 
Mazan et al. 1998; Lin, Liu et al. 2001), Wnt5a (Li, Xiao et al. 2002) and epithelial 
Wnt7b (Shu, Jiang et al. 2002). There are indications that modulating the Hedgehog 
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pathway can potentially affect canonical Wnt pathway and vice versa: Wnt2b and Wnt5a 
were candidate genes found to be upregulated in basal cell carcinomas with abnormal 
hedgehog signaling (Bonifas, Pennypacker et al. 2001; Mullor, Dahmane et al. 2001); 
Glycogen synthase kinase 3 (GSK3), a negative regulator of canonical Wnt signaling 
(Morin 1999; Kalderon 2002; Wharton 2003), has been shown to antagonize Hh 
signaling in Drosophila, by regulating the proteolysis of Ci (Aza-Blanc and Kornberg 
1999), the invertebrate counterpart of Gli and effector of Hh signaling (Jia, Amanai et al. 
2002; Price and Kalderon 2002).  
Wnt2 expression was found to be dramatically downregulated in Shh-/- lungs 
(Pepicelli, Lewis et al. 1998); however, whether Shh induces Wnt2 expression remains 
unclear since overexpression of Shh in the lung apparently did not result in Wnt2 
upregulation (Bellusci, Furuta et al. 1997). We show that some Wnt2 expression is 
restored in the Shh-/-;Gli3-/- (Figure 5.6 g-i ), suggesting Gli3R contributes, in part, to 
Wnt2 repression in Shh-/-. We found expressions of Wnt2b and Wnt5a were not 
significantly altered in the Shh-/- lung by RT-PCR (data not shown) and Wnt7b expression 
in the lung epithelium, which has been shown to regulate lung mesenchymal proliferation 
(Shu, Jiang et al. 2002), is not altered in Shh-/- (Pepicelli, Lewis et al. 1998). Two 
potential Wnt targets, Cyclin D1 and c-myc, were examined in this study; while Cyclin 
D1 is downregulated (Figure 5.4A,b), c-myc appears unaltered in Shh-/- lung (Figure 5.5-
b). Therefore, whether defective canonical Wnt signaling contributes to the hypoplastic 
Shh-/- lung phenotype remains unclear. Although we found that transcripts for several Wnt  
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Figure 5.6 Expression of developmentally regulated genes in WT, Shh−/−, and 
Shh−/−;Gli3−/− lungs. 
Whole-mount in situ hybridizations of WT, Shh−/−, and Shh−/−;Gli3−/− E12.5 lungs probed 
with Ptch1 (a–c), Gli1 (d–f), Wnt2 (g–i) and Foxf1 (j–l). As shown in e and f, Gli1, a Shh 
target, remains absent in Shh−/−;Gli3−/−, as in Shh−/− lungs. Ptch1 expression appears to be 
detectable, albeit at very low levels, in the mutant lungs (b and c), compared to WT lungs 
(a). The expressions of mesenchymal genes Wnt2 (g–i) and Foxf1 (j–l) appear to be 
relatively higher in the Shh−/−;Gli3−/− compared to Shh−/− lungs, although not as high as 
the expression in WT lungs (g,j). Magnification 320X. 
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ligands are not remarkably altered in Shh-/- lung, we ought to be circumspect given the 
possibility that the expressions or activities of Wnt mediators and signaling components 
such as the Frizzled family of receptors (Wang, Macke et al. 1996), Wnt antagonists such 
as secreted frizzled-related protein (sFRP) (Hsieh, Kodjabachian et al. 1999; Tebar, 
Destree et al. 2001; Heller, Dichmann et al. 2002) or other Wnt signaling effectors such 
as LEF1 and TCF transcription factors (Kengaku, Capdevila et al. 1998; Schmidt, Tanaka 
et al. 2000; Tebar, Destree et al. 2001; Kubo, Takeichi et al. 2003) may be altered in the 
Shh-/- lung and remain to be examined.  
 
Gli3R contributes to the repression of Foxf1 in the Shh-/- lung mesenchyme 
The murine Foxf1 gene (also known as Freac1 or Hfh8) (Clevidence, Overdier et 
al. 1994; Pierrou, Hellqvist et al. 1994; Hellqvist, Mahlapuu et al. 1996) encodes a 
forkhead or winged helix DNA-binding domain transcription factor. During 
organogenesis, Foxf1 is expressed in the splanchnic mesoderm adjacent to the gut 
endoderm, suggesting its potential involvement in epithelial-mesenchymal interactions 
(Peterson, Lim et al. 1997; Mahlapuu, Pelto-Huikko et al. 1998; Aitola, Carlsson et al. 
2000; Costa, Kalinichenko et al. 2001). Indeed, Foxf1 is downregulated in Shh-/- lung 
mesenchyme (Figure 5.6-k, E12.5 and Fig5.7-b, E15.5), although its expression in the 
Shh-/- lung has been previously reported absent (Mahlapuu, Enerback et al. 2001). This 
difference in Foxf1 expression could be attributed to variations in the length of exposure 
to the color detection medium after in situ hybridization. Nevertheless, our conclusion 
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that Shh signaling is required for the activation of Foxf1, based on its repression in Shh-/- 
lung, agrees with the previous report that Foxf1 is a target of Shh signaling (Mahlapuu, 
Enerback et al. 2001).  
The present study on Shh-/-;Gli3-/- lung reveals an interesting finding: Foxf1 is 
derepressed in Shh-/- lung in the absence of Gli3, although not to the levels expressed in 
age-matched WT lung (Figure 5.6-l, E12.5 and Figure 5.7-c, E15.5). This finding 
suggests Foxf1 transcriptional activation, in part, depends on Shh signaling and Gli2/3 
functions as previously proposed (Mahlapuu, Enerback et al. 2001), but it also implicates 
Gli3R as a negative regulator of Foxf1 transcription, emphasizing the critical role of Shh 
signaling in antagonizing Gli3R activity in the developing lung. Intriguingly, we also 
observed Foxf1 expression in E15.5 bronchial epithelium of WT and Shh-/- lungs (data 
not shown). Since Foxf1+/- haploinsufficient lungs are hypoplastic (Kalinichenko, Lim et 
al. 2001; Mahlapuu, Enerback et al. 2001; Lim, Kalinichenko et al. 2002) and a WT level 
of Foxf1 is required for normal lung development (Costa, Kalinichenko et al. 2001), we 
suggest upregulating Foxf1 expression in the Shh-/-;Gli3-/- lung may contribute, in part, to 
its increased growth potential compared with Shh-/- lung. Foxf1 has been implicated in 
growth control since proliferation of the primitive streak mesoderm is reduced in Foxf1 
null embryos (Mahlapuu, Ormestad et al. 2001) and it has been suggested that Foxf1 may 
mediate the mitogenic effect of Shh in the developing lung (Mahlapuu, Enerback et al. 
2001). However, the precise roles and targets of Foxf1 in governing cellular processes 
such as proliferation and differentiation in the developing lung await further investigation.  
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Figure 5.7 Expression of Foxf1 and Tbx genes in WT, Shh−/−, and Shh−/−;Gli3−/− 
lungs. 
Section in situ hybridizations on E15.5 WT, Shh−/− and Shh−/−;Gli3−/− lungs with Foxf1 
(a–c), Tbx2 (d–f), Tbx3 (g–i), Tbx4 (j–l), and Tbx5 (m–o). The levels of Foxf1, Tbx2, and 
Tbx3 transcripts are significantly reduced in Shh−/− but relatively higher in Shh−/−;Gli3−/− 
lungs. Tbx4 and Tbx5 transcripts appear only slightly lower in Shh−/− lungs. 
Magnification100X. 
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Tbx2 and Tbx3 expression are significantly repressed in Shh-/- and derepressed in 
Shh-/-;Gli3-/- lungs 
Based on recent literature, we next directed our efforts to examine the expression 
of T-box genes, which have been implicated as potential Fox targets (Kalinichenko, Lim 
et al. 2001; Yamagishi, Maeda et al. 2003), in the Shh mutant lungs. The T-box family 
comprises an ever-growing number of genes, now totaling eighteen in mammals (Gibson-
Brown 2002). T-box genes (Tbx) encode DNA binding transcription factors which 
regulate the functions of tissues during embryogenesis, in particular, tissues undergoing 
inductive interactions such as the lung epithelium which expresses Tbx1 and the 
mesenchyme which expresses two cognate gene sets: Tbx2; Tbx3 and Tbx4; Tbx5 
(Chapman, Garvey et al. 1996; Cebra-Thomas, Bromer et al. 2003). The Tbx factors have 
been implicated in human birth defects and cancer (Jacobs, Keblusek et al. 2000; 
Papaioannou 2001; Gibson-Brown 2002); however, the transcriptional regulators and 
targets of Tbx remain largely unexplored.  
 By cDNA expression array analysis and RNase protection assay, the Tbx family 
of transcription factors such as Tbx2, 3, 4 and 5, which like Foxf1, are expressed in the 
lung mesenchyme (Chapman, Garvey et al. 1996), were found to be diminished in 
Foxf1+/- mutant background (Kalinichenko, Lim et al. 2001), implicating the potential 
role of Foxf1 in the transcriptional regulation of Tbx genes. Since Foxf1 is downregulated 
in Shh-/- and partially derepressed in Shh-/-;Gli3-/- lungs, we decided to analyze the 
expression of Tbx2, 3 and Tbx4,5 in these mutants.  
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By using antisense oligonucleotide to abrogate the functions of both Tbx4 and 
Tbx5 (Cebra-Thomas, Bromer et al. 2003), it was shown that these transcription factors 
are likely important for the expression of mesenchymal Fgf10, critical in lung epithelial 
branching (Bellusci, Grindley et al. 1997; Weaver, Dunn et al. 2000). Fgf10 expression 
appears broader in Shh-/- lung (Litingtung, Lei et al. 1998; Pepicelli, Lewis et al. 1998); in 
agreement, expressions of Tbx4 and Tbx5 do not appear significantly altered in Shh-/- lung 
(Figure 5.7 k and n). In contrast Tbx2 and Tbx3 expression are significantly repressed in 
Shh-/- and enhanced in Shh-/-;Gli3-/- lungs (Figure 5.7 e,h and f,i). Our finding suggests 
Shh signaling is important in the transcriptional regulation of Tbx2 and Tbx3. While Tbx2 
and Tbx3 transcriptional activation by a Shh mediator such as Gli cannot be ruled out, 
previous reports have implicated other factors in the transcriptional induction of Tbx 
genes such as Bmp2 induction of Tbx2 in chick heart development (Yamada, Revelli et al. 
2000), Foxa2 and Foxc2 induction of Tbx1 in murine pharyngeal endoderm and head 
mesenchyme development, respectively (Yamagishi, Maeda et al. 2003). Shh signaling 
has been proposed to maintain the expression of Foxa2 and Foxc2 in the regulation of 
Tbx1 (Yamagishi, Maeda et al. 2003). Our observation that Tbx2 and Tbx3 expressions 
are significantly repressed in Shh-/- (Figure 5.7 e,h) and derepressed in Shh-/-;Gli3-/- lungs 
(Figure 5.7 f,i) bears good correlation with the Foxf1 expression levels in these mutants 
(Figure 5.7 b,c). Therefore, we suggest that Shh signaling regulates Tbx2 and Tbx3 
expression via Foxf1 in the developing lung. Consistent with this notion, Tbx2 and Tbx3 
expression are downregulated in Foxf1+/- lung (Kalinichenko, Lim et al. 2001). 
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Microarray analysis of Tbx2-induced gene expression revealed numerous, potentially 
interesting, transcriptional targets including genes involved in cell cycle control and cell 
adhesion (Chen, Zhong et al. 2001). Both Tbx2 and 3 have been linked to inhibition of 
senescence in primary mouse embryonic fibroblasts (Jacobs, Keblusek et al. 2000; 
Brummelkamp, Kortlever et al. 2002).  We suggest that Tbx2 and Tbx3 could also play a 
role in lung growth and proliferation; their downregulation could contibute, in part, to the 
Shh-/- hypoplastic lung phenotype. The specific role of Tbx2 and Tbx3 in lung 
development remains to be elucidated with the future identification of specific Tbx2- and 
Tbx3-regulated genes.   
 
Vasculogenesis is significantly impaired in Shh-/- and partially restored in Shh-/-; 
Gli3-/- lung  
During mouse embryogenesis, the lung mesenchyme undergoes a series of 
differentiation events with development of the pulmonary capillary network beginning 
around E10. It is believed that the capillary network is established when a subpopulation 
of lung mesenchymal cells undergo a process known as vasculogenesis which involves 
the migration and coalescence of these mesenchymal cells into blood islands or 
hemangioblast clusters, which are precursors of endothelial and hematopoietic cells 
(deMello, Sawyer et al. 1997; Akeson, Wetzel et al. 2000; Gebb and Shannon 2000; 
Schachtner, Wang et al. 2000). This capillary network, formed by lumenal connections 
and assembly of endothelial cells, is thought to eventually make connections with the 
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major pulmonary blood vessels to establish the lung circulatory system (deMello and 
Reid 2000; Hislop 2002). We examined the expression of markers associated with 
endothelial cell function such as platelet endothelial cell adhesion molecule-1 (PECAM-1) 
and vascular endothelial growth factor R2 (VEGF-R2), a receptor tyrosine kinase also 
known as fetal liver kinase-1 (Flk-1), to investigate the role of Shh signaling in 
pulmonary vasculogenesis. Flk-1 mediates signaling by VEGF, an endothelial-specific 
mitogen secreted by the lung epithelium (Gebb and Shannon 2000; Healy, Morgenthau et 
al. 2000) and has been shown to be critical for vasculogenesis and hematopoiesis 
(Shalaby, Rossant et al. 1995; Shalaby, Ho et al. 1997).  
Interestingly, we found the level of endothelial cell differentiation in the E15.5 
Shh-/- lung mesenchyme is reduced, based on PECAM-1 and Flk-1 staining, while Shh-/-
;Gli3-/- lung mesenchyme displays a relatively increased distribution of PECAM-1- and 
Flk-1-positive cells (Figure 5.8 b-c and h-i). PECAM-1 and Flk-1 staining show less 
continuity in Shh-/- (Figure 5.8 b,h), suggesting possible defects in migration and/or 
coalescence of endothelial cells to form the capillary bed (Akeson, Wetzel et al. 2000), 
while in Shh-/-;Gli3-/- lung, the severity of this problem appears alleviated based on the 
staining pattern of both endothelial markers (Figure 5.8 c,i). Flk-1 function has been 
linked to the movement of blood cell precursors (Shalaby, Ho et al. 1997). The present 
finding suggests that Shh signaling plays a critical role in the formation of the pulmonary 
capillary network. Moreover, the higher level of Gli3R in Shh-/- lung (Figure 5.2A, lane 1) 
appears to negatively regulate vasculogenesis which is less affected in Shh-/-;Gli3-/- lung.  
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Figure 5.8 Vasculogenesis appears to be enhanced in Shh−/−;Gli3−/− lung compared 
with Shh−/− lung.  
Cryosections of WT, Shh−/−, and Shh−/−;Gli3−/− E15.5 lungs were labeled with antibodies 
against PECAM-1 (a–f) and Flk-1(g–i), both endothelial markers, followed by Alexa 
488-conjugated secondary antibodies. PECAM-1-positive cells, in the interstitial 
mesenchyme, appear to be sparse in the Shh−/− but enhanced in Shh−/−;Gli3−/− lung 
(compare b and c). However, the uniform distribution of PECAM-1-positive endothelia 
from major pulmonary blood vessels is evident in all three genotypes and is not 
significantly different in the WT and mutant lungs (d–f). Flk-1 immunolabeling also 
reveals enhanced Flk-1-expressing cells in the interstitial mesenchyme of the 
Shh−/−;Gli3−/− lungs (i) compared with Shh−/− lungs (h). Magnification: a-c and g-I (100X), 
d-f (200X). 
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Foxf1 plays a critical role in pulmonary vasculogenesis because haploinsufficient 
Foxf1+/- embryos and newborn mice, expressing relatively low levels of Foxf1 in the lung 
(20% of wildtype levels) die of severe alveolar hemorrhage due to defects in 
vasculogenesis and alveologenesis (Kalinichenko, Lim et al. 2001).  These Foxf1+/- mice 
have diminished expression of PECAM-1 and Flk-1, whereas Foxf1+/- mice expressing 
near normal levels of Foxf1 displayed normal levels of PECAM-1 and Flk-1 
(Kalinichenko, Lim et al. 2001). In the adult mouse lung, Foxf1-expressing cells 
colocalized with PECAM-1-positive alveolar endothelial and peribronchiolar smooth 
muscle cells (Costa, Kalinichenko et al. 2001). PECAM-1 staining in the endothelium of 
large pulmonary blood vessels, which do not normally express Foxf1 (Kalinichenko, Lim 
et al. 2001), were comparable in all three genotypes (Figure5.8 d-f).  Among Foxf1+/- 
surviving adult mice, butylated hydroxytoluene (BHT) treatment causes fatal lung injury 
due to severe hemorrhage; BHT caused a 10-fold reduction in Foxf1 level accompanied 
by increased alveolar endothelial cell apoptosis (Kalinichenko, Zhou et al. 2002). Hence, 
it is plausible to suggest that the defect in PECAM-1 and Flk-1 expressions observed in 
the Shh-/- may be linked to repressed Foxf1 expression while Shh-/-;Gli3-/- lung, which 
expresses a relatively higher level of Foxf1, shows a concomitant recovery of endothelial 
marker expressions (Figure 5.8 c,i). However, it is possible that other factors are involved 
such as vascular endothelial growth factor (VEGF) (Zeng, Wert et al. 1998; Gebb and 
Shannon 2000; Healy, Morgenthau et al. 2000; Ng, Rohan et al. 2001; Galambos, Ng et al. 
2002) and TGF-beta1 (Zeng, Gray et al. 2001).  
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Foxf1+/- mice reported by another group also exhibited lung and foregut 
malformations resulting in 90% perinatal mortality but with apparently no significant 
defects in lung vascularization (Mahlapuu, Enerback et al. 2001). It is possible that the 
expression levels of Foxf1 in these mutant mice was not low enough to cause 
vasculogenesis problems but sufficiently downregulated to cause lung hypoplasia. It is 
apparent that there is variability in the levels of Foxf1 expressed from different Foxf1+/- 
embryos (Kalinichenko, Lim et al. 2001). This observation suggests that less than 
wildtype level of Foxf1 is sufficient to promote near normal vasculogenesis during early 
embryogenesis (Mahlapuu, Enerback et al. 2001), at least based on endothelial marker 
expression and distribution. In agreement, we observed enhanced vasculogenesis in Shh-/-
;Gli3-/- lung (Figure 5.8 c,i), although its Foxf1 transcript level is relatively less than 
wildtype (Figure 5.6 j, l and Figure 5.7 a,c). Foxf1, expressed in the mesenchyme, has 
been implicated in basement membrane extracellular matrix deposition and tight junction 
formation between cells of two interacting layers such as the mesenchymally-derived 
endothelial cell with Type I epithelial cell or the bronchial smooth muscle cell with the 
bronchiolar epithelium of the lung. Decreased Foxf1 expression has also been linked to 
gall bladder defects and reduced expression of adhesion molecules, vascular cell adhesion 
molecule-1 (VCAM-1) and α5 integrin (Kalinichenko, Zhou et al. 2002). Foxf1+/- mice 
show tight junction disruptions which could result in impaired epithelial-mesenchymal 
interaction (Costa, Kalinichenko et al. 2001; Kalinichenko, Lim et al. 2001; Kalinichenko, 
Lim et al. 2001), hence providing one plausible mechanism by which Foxf1 promotes 
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bronchial smooth muscle or endothelial cell homeostasis.  
 
Bronchial myogenesis remains defective in Shh-/-;Gli3-/- lung 
 The mesenchymal cells of the developing lung can give rise to visceral smooth 
muscle cells which express smooth muscle alpha-actin (SMA) and smooth muscle 
myosin (SMM) (Yang, Palmer et al. 1998; Yang, Relan et al. 1999). Since vasculogenesis 
defect is less impaired in the Shh-/-;Gli3-/- lung compared to the Shh-/- lung, we thought it 
would be interesting to examine whether differentiation along another cell lineage, 
namely bronchial smooth muscle (BSM), which is absent in the Shh-/- lung (Pepicelli, 
Lewis et al. 1998), would be restored in Shh-/-;Gli3-/- lung. Moreover, Foxf1 expression is 
relatively higher in Shh-/-;Gli3-/- lung compared with Shh-/- lung, so we wondered whether 
this increase would be accompanied by a concomitant recovery of BSM in Shh-/-;Gli3-/- 
lung, since Foxf1 is expressed in the peribronchiolar smooth muscle layer (Costa, 
Kalinichenko et al. 2001; Kalinichenko, Lim et al. 2001) and has been implicated in Shh-
induced myogenesis in lung mesenchyme explants (Weaver, Batts et al. 2003). In Foxf1+/- 
newborn lung, a disruption of the cell interface between the BSM and epithelial layers 
was reported along with an increase in apoptosis of BSM cells (Kalinichenko, Lim et al. 
2001). Our results, by immunohistochemistry using both SMA and SMM antibodies on 
E15.5 lungs, indicate that, while vascular smooth muscles lining the major pulmonary 
blood vessels (Hall, Hislop et al. 2000; Hall, Hislop et al. 2002; Hislop 2002) are present 
in both Shh-/- and Shh-/-;Gli3-/- lungs (Figure 5.9 arrows in b,c,e,f ), bronchial smooth 
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Figure 5.9 Bronchial myogenesis remains absent in Shh−/−;Gli3−/− lung compared 
with Shh−/− lung.  
Cryosections of wild-type (WT), Shh−/−, and Shh−/−;Gli3−/− E15.5 lungs were labeled with 
antibodies against smooth muscle actin (SMA) (a–c) and smooth muscle myosin (SMM) 
(d–f), followed by Alexa 488 (a–c) or Alexa 568 (d–f) conjugated secondary antibodies. 
While vascular smooth muscle is present in the mutants (arrows) and WT lungs (d–f), 
bronchial smooth muscle as highlighted by SMA (a–c) and SMM (d–f) is evident in the 
WT (arrowheads) but absent in the Shh−/−;Gli3−/− lung (arrowheads), as in Shh−/− 
(arrowheads). Magnification: 100X. 
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 muscle remains absent (Figure 5.9 arrowheads in b,c,e,f). The WT lung shows clear 
presence of bronchial smooth muscle as highlighted by the smooth muscle markers 
(Figure 5.9 arrowheads in a,d). This finding suggests that while differentiation along the 
alveolar capillary endothelial cell lineage is enhanced in Shh-/-;Gli3-/- lungs, 
differentiation along the bronchial smooth muscle lineage remains defective. This 
observation implies that Gli3R does not contribute significantly to the lack of BSM in 
Shh-/- lung. In conclusion, our result suggests while upregulating Foxf1, implicated in 
pulmonary vasculogenesis, in Shh-/-;Gli3-/- lung  partially restored the distribution of 
PECAM-positive endothelial cell types, in contrast, that level of Foxf1 is not sufficient to 
restore BSM.  Hence, the role of Foxf1 in bronchial myogenesis awaits further 
investigation.  
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